WO2019154879A1 - Composition comprising spray dried roe - Google Patents
Composition comprising spray dried roe Download PDFInfo
- Publication number
- WO2019154879A1 WO2019154879A1 PCT/EP2019/052943 EP2019052943W WO2019154879A1 WO 2019154879 A1 WO2019154879 A1 WO 2019154879A1 EP 2019052943 W EP2019052943 W EP 2019052943W WO 2019154879 A1 WO2019154879 A1 WO 2019154879A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- roe
- spray dried
- composition
- dried roe
- present
- Prior art date
Links
- 239000007921 spray Substances 0.000 title claims abstract description 167
- 239000000203 mixture Substances 0.000 title claims abstract description 76
- 239000000843 powder Substances 0.000 claims abstract description 21
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 20
- 235000013305 food Nutrition 0.000 claims description 45
- 238000000034 method Methods 0.000 claims description 33
- 235000015872 dietary supplement Nutrition 0.000 claims description 32
- 230000008569 process Effects 0.000 claims description 30
- 150000002632 lipids Chemical class 0.000 claims description 28
- 239000004615 ingredient Substances 0.000 claims description 22
- 108090000623 proteins and genes Proteins 0.000 claims description 20
- 102000004169 proteins and genes Human genes 0.000 claims description 20
- 235000020660 omega-3 fatty acid Nutrition 0.000 claims description 18
- VFLDPWHFBUODDF-FCXRPNKRSA-N curcumin Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)CC(=O)\C=C\C=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-FCXRPNKRSA-N 0.000 claims description 17
- 238000001694 spray drying Methods 0.000 claims description 17
- JAZBEHYOTPTENJ-JLNKQSITSA-N all-cis-5,8,11,14,17-icosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 claims description 16
- 235000020669 docosahexaenoic acid Nutrition 0.000 claims description 16
- 235000020673 eicosapentaenoic acid Nutrition 0.000 claims description 16
- 229960005135 eicosapentaenoic acid Drugs 0.000 claims description 16
- JAZBEHYOTPTENJ-UHFFFAOYSA-N eicosapentaenoic acid Natural products CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O JAZBEHYOTPTENJ-UHFFFAOYSA-N 0.000 claims description 16
- 229940012843 omega-3 fatty acid Drugs 0.000 claims description 15
- 238000004519 manufacturing process Methods 0.000 claims description 14
- 239000006014 omega-3 oil Substances 0.000 claims description 12
- 241001465754 Metazoa Species 0.000 claims description 11
- 241000252203 Clupea harengus Species 0.000 claims description 10
- 239000003963 antioxidant agent Substances 0.000 claims description 10
- 235000019514 herring Nutrition 0.000 claims description 10
- 235000012754 curcumin Nutrition 0.000 claims description 8
- 239000004148 curcumin Substances 0.000 claims description 8
- 229940109262 curcumin Drugs 0.000 claims description 8
- VFLDPWHFBUODDF-UHFFFAOYSA-N diferuloylmethane Natural products C1=C(O)C(OC)=CC(C=CC(=O)CC(=O)C=CC=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-UHFFFAOYSA-N 0.000 claims description 8
- DVSZKTAMJJTWFG-SKCDLICFSA-N (2e,4e,6e,8e,10e,12e)-docosa-2,4,6,8,10,12-hexaenoic acid Chemical compound CCCCCCCCC\C=C\C=C\C=C\C=C\C=C\C=C\C(O)=O DVSZKTAMJJTWFG-SKCDLICFSA-N 0.000 claims description 6
- GZJLLYHBALOKEX-UHFFFAOYSA-N 6-Ketone, O18-Me-Ussuriedine Natural products CC=CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O GZJLLYHBALOKEX-UHFFFAOYSA-N 0.000 claims description 6
- KAUVQQXNCKESLC-UHFFFAOYSA-N docosahexaenoic acid (DHA) Natural products COC(=O)C(C)NOCC1=CC=CC=C1 KAUVQQXNCKESLC-UHFFFAOYSA-N 0.000 claims description 6
- 235000020665 omega-6 fatty acid Nutrition 0.000 claims description 6
- 229940033080 omega-6 fatty acid Drugs 0.000 claims description 6
- PFNFFQXMRSDOHW-UHFFFAOYSA-N spermine Chemical compound NCCCNCCCCNCCCN PFNFFQXMRSDOHW-UHFFFAOYSA-N 0.000 claims description 6
- 241000972773 Aulopiformes Species 0.000 claims description 4
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 claims description 4
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 claims description 4
- 241001417902 Mallotus villosus Species 0.000 claims description 4
- 235000019515 salmon Nutrition 0.000 claims description 4
- 241000276498 Pollachius virens Species 0.000 claims description 3
- 239000008194 pharmaceutical composition Substances 0.000 claims description 3
- 229940063675 spermine Drugs 0.000 claims description 3
- 241000238557 Decapoda Species 0.000 claims description 2
- 239000000047 product Substances 0.000 description 22
- 235000016709 nutrition Nutrition 0.000 description 21
- MBMBGCFOFBJSGT-KUBAVDMBSA-N all-cis-docosa-4,7,10,13,16,19-hexaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 description 20
- 235000018102 proteins Nutrition 0.000 description 19
- 235000019688 fish Nutrition 0.000 description 15
- 241000251468 Actinopterygii Species 0.000 description 14
- -1 1 1 -cis-retinal Chemical compound 0.000 description 11
- 235000008429 bread Nutrition 0.000 description 11
- 239000002245 particle Substances 0.000 description 11
- 229940090949 docosahexaenoic acid Drugs 0.000 description 10
- 239000000796 flavoring agent Substances 0.000 description 10
- 230000035764 nutrition Effects 0.000 description 10
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
- 235000001014 amino acid Nutrition 0.000 description 9
- 150000001413 amino acids Chemical class 0.000 description 9
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 9
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 8
- 235000006708 antioxidants Nutrition 0.000 description 8
- 239000011248 coating agent Substances 0.000 description 8
- 238000000576 coating method Methods 0.000 description 8
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 description 8
- 235000002639 sodium chloride Nutrition 0.000 description 8
- 239000013589 supplement Substances 0.000 description 8
- 238000004040 coloring Methods 0.000 description 7
- 235000015220 hamburgers Nutrition 0.000 description 7
- 150000002430 hydrocarbons Chemical group 0.000 description 7
- 150000003839 salts Chemical class 0.000 description 7
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 6
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- 235000005911 diet Nutrition 0.000 description 5
- 235000013601 eggs Nutrition 0.000 description 5
- 235000019634 flavors Nutrition 0.000 description 5
- 239000003921 oil Substances 0.000 description 5
- 235000019198 oils Nutrition 0.000 description 5
- 230000003647 oxidation Effects 0.000 description 5
- 238000007254 oxidation reaction Methods 0.000 description 5
- 239000003755 preservative agent Substances 0.000 description 5
- 235000019465 surimi Nutrition 0.000 description 5
- 241000442132 Lactarius lactarius Species 0.000 description 4
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 4
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical group [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 4
- 229910052782 aluminium Inorganic materials 0.000 description 4
- 235000015173 baked goods and baking mixes Nutrition 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- HUMNYLRZRPPJDN-UHFFFAOYSA-N benzaldehyde Chemical compound O=CC1=CC=CC=C1 HUMNYLRZRPPJDN-UHFFFAOYSA-N 0.000 description 4
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 4
- 210000004556 brain Anatomy 0.000 description 4
- FDSDTBUPSURDBL-LOFNIBRQSA-N canthaxanthin Chemical compound CC=1C(=O)CCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)CCC1(C)C FDSDTBUPSURDBL-LOFNIBRQSA-N 0.000 description 4
- 238000005538 encapsulation Methods 0.000 description 4
- 235000020776 essential amino acid Nutrition 0.000 description 4
- 239000003797 essential amino acid Substances 0.000 description 4
- 239000000284 extract Substances 0.000 description 4
- 235000013312 flour Nutrition 0.000 description 4
- 235000003599 food sweetener Nutrition 0.000 description 4
- 235000013350 formula milk Nutrition 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 230000007935 neutral effect Effects 0.000 description 4
- 235000015097 nutrients Nutrition 0.000 description 4
- WTJKGGKOPKCXLL-RRHRGVEJSA-N phosphatidylcholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCCCCCC WTJKGGKOPKCXLL-RRHRGVEJSA-N 0.000 description 4
- 108090000765 processed proteins & peptides Proteins 0.000 description 4
- 102000004196 processed proteins & peptides Human genes 0.000 description 4
- 239000003765 sweetening agent Substances 0.000 description 4
- 238000005406 washing Methods 0.000 description 4
- 244000144725 Amygdalus communis Species 0.000 description 3
- 235000011437 Amygdalus communis Nutrition 0.000 description 3
- 241000167854 Bourreria succulenta Species 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 244000299461 Theobroma cacao Species 0.000 description 3
- 229930003427 Vitamin E Natural products 0.000 description 3
- 239000000654 additive Substances 0.000 description 3
- 235000020224 almond Nutrition 0.000 description 3
- 235000010323 ascorbic acid Nutrition 0.000 description 3
- 239000011668 ascorbic acid Substances 0.000 description 3
- 229960005070 ascorbic acid Drugs 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- 239000011230 binding agent Substances 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 125000004432 carbon atom Chemical group C* 0.000 description 3
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 235000019693 cherries Nutrition 0.000 description 3
- 235000015165 citric acid Nutrition 0.000 description 3
- 235000020971 citrus fruits Nutrition 0.000 description 3
- CYQFCXCEBYINGO-IAGOWNOFSA-N delta1-THC Chemical compound C1=C(C)CC[C@H]2C(C)(C)OC3=CC(CCCCC)=CC(O)=C3[C@@H]21 CYQFCXCEBYINGO-IAGOWNOFSA-N 0.000 description 3
- 230000006866 deterioration Effects 0.000 description 3
- 230000037213 diet Effects 0.000 description 3
- 235000014113 dietary fatty acids Nutrition 0.000 description 3
- 235000013399 edible fruits Nutrition 0.000 description 3
- 235000019197 fats Nutrition 0.000 description 3
- 229930195729 fatty acid Natural products 0.000 description 3
- 239000000194 fatty acid Substances 0.000 description 3
- 150000004665 fatty acids Chemical class 0.000 description 3
- 239000000945 filler Substances 0.000 description 3
- 230000037406 food intake Effects 0.000 description 3
- 238000007710 freezing Methods 0.000 description 3
- 230000008014 freezing Effects 0.000 description 3
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 3
- 239000007789 gas Substances 0.000 description 3
- 229910052500 inorganic mineral Inorganic materials 0.000 description 3
- 235000020667 long-chain omega-3 fatty acid Nutrition 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 235000012054 meals Nutrition 0.000 description 3
- 235000010755 mineral Nutrition 0.000 description 3
- 239000011707 mineral Substances 0.000 description 3
- 239000003607 modifier Substances 0.000 description 3
- WTEVQBCEXWBHNA-YFHOEESVSA-N neral Chemical compound CC(C)=CCC\C(C)=C/C=O WTEVQBCEXWBHNA-YFHOEESVSA-N 0.000 description 3
- 150000003904 phospholipids Chemical class 0.000 description 3
- 238000002203 pretreatment Methods 0.000 description 3
- 235000019204 saccharin Nutrition 0.000 description 3
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 3
- 229940081974 saccharin Drugs 0.000 description 3
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 3
- 235000011888 snacks Nutrition 0.000 description 3
- 239000002594 sorbent Substances 0.000 description 3
- 238000003860 storage Methods 0.000 description 3
- 239000004094 surface-active agent Substances 0.000 description 3
- 235000019165 vitamin E Nutrition 0.000 description 3
- 229940046009 vitamin E Drugs 0.000 description 3
- 239000011709 vitamin E Substances 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- YUFFSWGQGVEMMI-JLNKQSITSA-N (7Z,10Z,13Z,16Z,19Z)-docosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCCCC(O)=O YUFFSWGQGVEMMI-JLNKQSITSA-N 0.000 description 2
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- PHIQHXFUZVPYII-ZCFIWIBFSA-O (R)-carnitinium Chemical compound C[N+](C)(C)C[C@H](O)CC(O)=O PHIQHXFUZVPYII-ZCFIWIBFSA-O 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 2
- ROWKJAVDOGWPAT-UHFFFAOYSA-N Acetoin Chemical compound CC(O)C(C)=O ROWKJAVDOGWPAT-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 239000005711 Benzoic acid Substances 0.000 description 2
- 235000002566 Capsicum Nutrition 0.000 description 2
- 235000008534 Capsicum annuum var annuum Nutrition 0.000 description 2
- 244000223760 Cinnamomum zeylanicum Species 0.000 description 2
- WTEVQBCEXWBHNA-UHFFFAOYSA-N Citral Natural products CC(C)=CCCC(C)=CC=O WTEVQBCEXWBHNA-UHFFFAOYSA-N 0.000 description 2
- 235000005979 Citrus limon Nutrition 0.000 description 2
- 244000131522 Citrus pyriformis Species 0.000 description 2
- RGJOEKWQDUBAIZ-IBOSZNHHSA-N CoASH Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCS)O[C@H]1N1C2=NC=NC(N)=C2N=C1 RGJOEKWQDUBAIZ-IBOSZNHHSA-N 0.000 description 2
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 2
- 235000021294 Docosapentaenoic acid Nutrition 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- 241000287828 Gallus gallus Species 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 239000006002 Pepper Substances 0.000 description 2
- OOUTWVMJGMVRQF-DOYZGLONSA-N Phoenicoxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)C(=O)C(O)CC1(C)C)C=CC=C(/C)C=CC2=C(C)C(=O)CCC2(C)C OOUTWVMJGMVRQF-DOYZGLONSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 235000016761 Piper aduncum Nutrition 0.000 description 2
- 240000003889 Piper guineense Species 0.000 description 2
- 235000017804 Piper guineense Nutrition 0.000 description 2
- 235000008184 Piper nigrum Nutrition 0.000 description 2
- DLRVVLDZNNYCBX-UHFFFAOYSA-N Polydextrose Polymers OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(O)O1 DLRVVLDZNNYCBX-UHFFFAOYSA-N 0.000 description 2
- VYGQUTWHTHXGQB-FFHKNEKCSA-N Retinol Palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-FFHKNEKCSA-N 0.000 description 2
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 2
- 239000004376 Sucralose Substances 0.000 description 2
- RAHZWNYVWXNFOC-UHFFFAOYSA-N Sulphur dioxide Chemical compound O=S=O RAHZWNYVWXNFOC-UHFFFAOYSA-N 0.000 description 2
- 244000078534 Vaccinium myrtillus Species 0.000 description 2
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 2
- 235000009754 Vitis X bourquina Nutrition 0.000 description 2
- 235000012333 Vitis X labruscana Nutrition 0.000 description 2
- 240000006365 Vitis vinifera Species 0.000 description 2
- 235000014787 Vitis vinifera Nutrition 0.000 description 2
- 108010046377 Whey Proteins Proteins 0.000 description 2
- 102000007544 Whey Proteins Human genes 0.000 description 2
- 235000011054 acetic acid Nutrition 0.000 description 2
- 230000000996 additive effect Effects 0.000 description 2
- 150000001299 aldehydes Chemical class 0.000 description 2
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 2
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 2
- AZDRQVAHHNSJOQ-UHFFFAOYSA-N alumane Chemical class [AlH3] AZDRQVAHHNSJOQ-UHFFFAOYSA-N 0.000 description 2
- 235000019728 animal nutrition Nutrition 0.000 description 2
- 238000009360 aquaculture Methods 0.000 description 2
- 244000144974 aquaculture Species 0.000 description 2
- 239000012298 atmosphere Substances 0.000 description 2
- 235000008452 baby food Nutrition 0.000 description 2
- 229940095076 benzaldehyde Drugs 0.000 description 2
- 235000010233 benzoic acid Nutrition 0.000 description 2
- 235000013734 beta-carotene Nutrition 0.000 description 2
- 239000011648 beta-carotene Substances 0.000 description 2
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 2
- 229960002747 betacarotene Drugs 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 235000012682 canthaxanthin Nutrition 0.000 description 2
- 239000001659 canthaxanthin Substances 0.000 description 2
- 229940008033 canthaxanthin Drugs 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 125000002843 carboxylic acid group Chemical group 0.000 description 2
- 235000012730 carminic acid Nutrition 0.000 description 2
- 229960004203 carnitine Drugs 0.000 description 2
- 235000013330 chicken meat Nutrition 0.000 description 2
- 235000019219 chocolate Nutrition 0.000 description 2
- 210000001136 chorion Anatomy 0.000 description 2
- 235000017803 cinnamon Nutrition 0.000 description 2
- RGJOEKWQDUBAIZ-UHFFFAOYSA-N coenzime A Natural products OC1C(OP(O)(O)=O)C(COP(O)(=O)OP(O)(=O)OCC(C)(C)C(O)C(=O)NCCC(=O)NCCS)OC1N1C2=NC=NC(N)=C2N=C1 RGJOEKWQDUBAIZ-UHFFFAOYSA-N 0.000 description 2
- 239000005516 coenzyme A Substances 0.000 description 2
- 229940093530 coenzyme a Drugs 0.000 description 2
- 239000000625 cyclamic acid and its Na and Ca salt Substances 0.000 description 2
- HCAJEUSONLESMK-UHFFFAOYSA-N cyclohexylsulfamic acid Chemical compound OS(=O)(=O)NC1CCCCC1 HCAJEUSONLESMK-UHFFFAOYSA-N 0.000 description 2
- 235000013365 dairy product Nutrition 0.000 description 2
- KSMVZQYAVGTKIV-UHFFFAOYSA-N decanal Chemical compound CCCCCCCCCC=O KSMVZQYAVGTKIV-UHFFFAOYSA-N 0.000 description 2
- KDTSHFARGAKYJN-UHFFFAOYSA-N dephosphocoenzyme A Natural products OC1C(O)C(COP(O)(=O)OP(O)(=O)OCC(C)(C)C(O)C(=O)NCCC(=O)NCCS)OC1N1C2=NC=NC(N)=C2N=C1 KDTSHFARGAKYJN-UHFFFAOYSA-N 0.000 description 2
- 230000000378 dietary effect Effects 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- FKRCODPIKNYEAC-UHFFFAOYSA-N ethyl propionate Chemical compound CCOC(=O)CC FKRCODPIKNYEAC-UHFFFAOYSA-N 0.000 description 2
- CBOQJANXLMLOSS-UHFFFAOYSA-N ethyl vanillin Chemical compound CCOC1=CC(C=O)=CC=C1O CBOQJANXLMLOSS-UHFFFAOYSA-N 0.000 description 2
- 229940013317 fish oils Drugs 0.000 description 2
- 235000013332 fish product Nutrition 0.000 description 2
- 235000019162 flavin adenine dinucleotide Nutrition 0.000 description 2
- 239000011714 flavin adenine dinucleotide Substances 0.000 description 2
- VWWQXMAJTJZDQX-UYBVJOGSSA-N flavin adenine dinucleotide Chemical compound C1=NC2=C(N)N=CN=C2N1[C@@H]([C@H](O)[C@@H]1O)O[C@@H]1CO[P@](O)(=O)O[P@@](O)(=O)OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C2=NC(=O)NC(=O)C2=NC2=C1C=C(C)C(C)=C2 VWWQXMAJTJZDQX-UYBVJOGSSA-N 0.000 description 2
- 229940093632 flavin-adenine dinucleotide Drugs 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 235000012041 food component Nutrition 0.000 description 2
- 238000004108 freeze drying Methods 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 2
- WTEVQBCEXWBHNA-JXMROGBWSA-N geranial Chemical compound CC(C)=CCC\C(C)=C\C=O WTEVQBCEXWBHNA-JXMROGBWSA-N 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 230000007407 health benefit Effects 0.000 description 2
- MLFHJEHSLIIPHL-UHFFFAOYSA-N isoamyl acetate Chemical compound CC(C)CCOC(C)=O MLFHJEHSLIIPHL-UHFFFAOYSA-N 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 235000019223 lemon-lime Nutrition 0.000 description 2
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 description 2
- 235000013372 meat Nutrition 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- VAMXMNNIEUEQDV-UHFFFAOYSA-N methyl anthranilate Chemical compound COC(=O)C1=CC=CC=C1N VAMXMNNIEUEQDV-UHFFFAOYSA-N 0.000 description 2
- OSWPMRLSEDHDFF-UHFFFAOYSA-N methyl salicylate Chemical compound COC(=O)C1=CC=CC=C1O OSWPMRLSEDHDFF-UHFFFAOYSA-N 0.000 description 2
- 230000001537 neural effect Effects 0.000 description 2
- 238000004806 packaging method and process Methods 0.000 description 2
- QNGNSVIICDLXHT-UHFFFAOYSA-N para-ethylbenzaldehyde Natural products CCC1=CC=C(C=O)C=C1 QNGNSVIICDLXHT-UHFFFAOYSA-N 0.000 description 2
- 235000012736 patent blue V Nutrition 0.000 description 2
- 239000004177 patent blue V Substances 0.000 description 2
- 229920001184 polypeptide Polymers 0.000 description 2
- 235000012731 ponceau 4R Nutrition 0.000 description 2
- 239000004175 ponceau 4R Substances 0.000 description 2
- NGVDGCNFYWLIFO-UHFFFAOYSA-N pyridoxal 5'-phosphate Chemical compound CC1=NC=C(COP(O)(O)=O)C(C=O)=C1O NGVDGCNFYWLIFO-UHFFFAOYSA-N 0.000 description 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 2
- 235000012752 quinoline yellow Nutrition 0.000 description 2
- 239000004172 quinoline yellow Substances 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 210000001525 retina Anatomy 0.000 description 2
- 235000019192 riboflavin Nutrition 0.000 description 2
- 239000002151 riboflavin Substances 0.000 description 2
- 229960002477 riboflavin Drugs 0.000 description 2
- 235000011649 selenium Nutrition 0.000 description 2
- 229910052711 selenium Inorganic materials 0.000 description 2
- 239000011669 selenium Substances 0.000 description 2
- 239000002002 slurry Substances 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 235000010356 sorbitol Nutrition 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 235000019408 sucralose Nutrition 0.000 description 2
- BAQAVOSOZGMPRM-QBMZZYIRSA-N sucralose Chemical compound O[C@@H]1[C@@H](O)[C@@H](Cl)[C@@H](CO)O[C@@H]1O[C@@]1(CCl)[C@@H](O)[C@H](O)[C@@H](CCl)O1 BAQAVOSOZGMPRM-QBMZZYIRSA-N 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- JZRWCGZRTZMZEH-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 2
- 235000008170 thiamine pyrophosphate Nutrition 0.000 description 2
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical compound CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 description 2
- 235000019155 vitamin A Nutrition 0.000 description 2
- 239000011719 vitamin A Substances 0.000 description 2
- 229940045997 vitamin a Drugs 0.000 description 2
- 210000001534 vitelline membrane Anatomy 0.000 description 2
- 239000000341 volatile oil Substances 0.000 description 2
- 235000021119 whey protein Nutrition 0.000 description 2
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 2
- RMLYXMMBIZLGAQ-UHFFFAOYSA-N (-)-monatin Natural products C1=CC=C2C(CC(O)(CC(N)C(O)=O)C(O)=O)=CNC2=C1 RMLYXMMBIZLGAQ-UHFFFAOYSA-N 0.000 description 1
- AUHDWARTFSKSAC-HEIFUQTGSA-N (2S,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)-2-(6-oxo-1H-purin-9-yl)oxolane-2-carboxylic acid Chemical class [C@]1([C@H](O)[C@H](O)[C@@H](CO)O1)(N1C=NC=2C(O)=NC=NC12)C(=O)O AUHDWARTFSKSAC-HEIFUQTGSA-N 0.000 description 1
- RMLYXMMBIZLGAQ-HZMBPMFUSA-N (2s,4s)-4-amino-2-hydroxy-2-(1h-indol-3-ylmethyl)pentanedioic acid Chemical compound C1=CC=C2C(C[C@](O)(C[C@H](N)C(O)=O)C(O)=O)=CNC2=C1 RMLYXMMBIZLGAQ-HZMBPMFUSA-N 0.000 description 1
- QZOALWMSYRBZSA-PDSBIMDKSA-N (3r,5r,8r,9r,10r,13s,14r)-3-[(2r,3r,4s,5s,6r)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-10,13-dimethyl-17-[(1s)-1-[(2r,5s,6r)-5-methyl-6-[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@H]1C[C@H]2C(=O)C[C@@H]3[C@H]4CCC([C@]4(CC[C@H]3[C@@]2(C)CC1)C)[C@H](C)[C@@H]1O[C@H](O[C@H]2[C@@H]([C@H](O)[C@@H](O)[C@H](C)O2)O)[C@@H](C)CC1)[C@@H]1O[C@@H](C)[C@H](O)[C@@H](O)[C@H]1O QZOALWMSYRBZSA-PDSBIMDKSA-N 0.000 description 1
- YTKBWWKAVMSYHE-OALUTQOASA-N (3s)-3-[3-(3-hydroxy-4-methoxyphenyl)propylamino]-4-[[(2s)-1-methoxy-1-oxo-3-phenylpropan-2-yl]amino]-4-oxobutanoic acid Chemical compound C([C@@H](C(=O)OC)NC(=O)[C@H](CC(O)=O)NCCCC=1C=C(O)C(OC)=CC=1)C1=CC=CC=C1 YTKBWWKAVMSYHE-OALUTQOASA-N 0.000 description 1
- KVHQNWGLVVERFR-ACMTZBLWSA-N (3s)-3-amino-4-[[(2s)-1-methoxy-1-oxo-3-phenylpropan-2-yl]amino]-4-oxobutanoic acid;6-methyl-2,2-dioxooxathiazin-4-one Chemical compound CC1=CC(=O)[NH2+]S(=O)(=O)O1.[O-]C(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 KVHQNWGLVVERFR-ACMTZBLWSA-N 0.000 description 1
- NUFKRGBSZPCGQB-FLBSXDLDSA-N (3s)-3-amino-4-oxo-4-[[(2r)-1-oxo-1-[(2,2,4,4-tetramethylthietan-3-yl)amino]propan-2-yl]amino]butanoic acid;pentahydrate Chemical compound O.O.O.O.O.OC(=O)C[C@H](N)C(=O)N[C@H](C)C(=O)NC1C(C)(C)SC1(C)C.OC(=O)C[C@H](N)C(=O)N[C@H](C)C(=O)NC1C(C)(C)SC1(C)C NUFKRGBSZPCGQB-FLBSXDLDSA-N 0.000 description 1
- KJPRLNWUNMBNBZ-QPJJXVBHSA-N (E)-cinnamaldehyde Chemical compound O=C\C=C\C1=CC=CC=C1 KJPRLNWUNMBNBZ-QPJJXVBHSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- SERLAGPUMNYUCK-DCUALPFSSA-N 1-O-alpha-D-glucopyranosyl-D-mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O SERLAGPUMNYUCK-DCUALPFSSA-N 0.000 description 1
- CBOBADCVMLMQRW-UHFFFAOYSA-N 2,6-dimethyloctanal Chemical compound CCC(C)CCCC(C)C=O CBOBADCVMLMQRW-UHFFFAOYSA-N 0.000 description 1
- RCSBILYQLVXLJG-UHFFFAOYSA-N 2-Propenyl hexanoate Chemical compound CCCCCC(=O)OCC=C RCSBILYQLVXLJG-UHFFFAOYSA-N 0.000 description 1
- DEQJBORXLQWRGV-UHFFFAOYSA-N 2-hydroxypropanoic acid;iron Chemical compound [Fe].CC(O)C(O)=O.CC(O)C(O)=O DEQJBORXLQWRGV-UHFFFAOYSA-N 0.000 description 1
- MIDXCONKKJTLDX-UHFFFAOYSA-N 3,5-dimethylcyclopentane-1,2-dione Chemical compound CC1CC(C)C(=O)C1=O MIDXCONKKJTLDX-UHFFFAOYSA-N 0.000 description 1
- MSTNYGQPCMXVAQ-KIYNQFGBSA-N 5,6,7,8-tetrahydrofolic acid Chemical compound N1C=2C(=O)NC(N)=NC=2NCC1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 MSTNYGQPCMXVAQ-KIYNQFGBSA-N 0.000 description 1
- RXQCEGOUSFBKPI-UHFFFAOYSA-N 5-Nitro-2-propoxyaniline Chemical compound CCCOC1=CC=C([N+]([O-])=O)C=C1N RXQCEGOUSFBKPI-UHFFFAOYSA-N 0.000 description 1
- PVXPPJIGRGXGCY-TZLCEDOOSA-N 6-O-alpha-D-glucopyranosyl-D-fructofuranose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)C(O)(CO)O1 PVXPPJIGRGXGCY-TZLCEDOOSA-N 0.000 description 1
- DFMMVLFMMAQXHZ-DOKBYWHISA-N 8'-apo-beta,psi-caroten-8'-al Chemical compound O=CC(/C)=C/C=C/C(/C)=C/C=C/C=C(\C)/C=C/C=C(\C)/C=C/C1=C(C)CCCC1(C)C DFMMVLFMMAQXHZ-DOKBYWHISA-N 0.000 description 1
- WBZFUFAFFUEMEI-UHFFFAOYSA-M Acesulfame k Chemical compound [K+].CC1=CC(=O)[N-]S(=O)(=O)O1 WBZFUFAFFUEMEI-UHFFFAOYSA-M 0.000 description 1
- 239000004394 Advantame Substances 0.000 description 1
- 239000004377 Alitame Substances 0.000 description 1
- 244000144730 Amygdalus persica Species 0.000 description 1
- 244000226021 Anacardium occidentale Species 0.000 description 1
- 244000099147 Ananas comosus Species 0.000 description 1
- 235000007119 Ananas comosus Nutrition 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- 239000004385 Aspartame-acesulfame salt Substances 0.000 description 1
- JEBFVOLFMLUKLF-IFPLVEIFSA-N Astaxanthin Natural products CC(=C/C=C/C(=C/C=C/C1=C(C)C(=O)C(O)CC1(C)C)/C)C=CC=C(/C)C=CC=C(/C)C=CC2=C(C)C(=O)C(O)CC2(C)C JEBFVOLFMLUKLF-IFPLVEIFSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- HRQKOYFGHJYEFS-UHFFFAOYSA-N Beta psi-carotene Chemical compound CC(C)=CCCC(C)=CC=CC(C)=CC=CC(C)=CC=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C HRQKOYFGHJYEFS-UHFFFAOYSA-N 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- SGHZXLIDFTYFHQ-UHFFFAOYSA-L Brilliant Blue Chemical compound [Na+].[Na+].C=1C=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C(=CC=CC=2)S([O-])(=O)=O)C=CC=1N(CC)CC1=CC=CC(S([O-])(=O)=O)=C1 SGHZXLIDFTYFHQ-UHFFFAOYSA-L 0.000 description 1
- 239000004255 Butylated hydroxyanisole Substances 0.000 description 1
- 239000004322 Butylated hydroxytoluene Substances 0.000 description 1
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 1
- RTMBGDBBDQKNNZ-UHFFFAOYSA-L C.I. Acid Blue 3 Chemical compound [Ca+2].C1=CC(N(CC)CC)=CC=C1C(C=1C(=CC(=C(O)C=1)S([O-])(=O)=O)S([O-])(=O)=O)=C1C=CC(=[N+](CC)CC)C=C1.C1=CC(N(CC)CC)=CC=C1C(C=1C(=CC(=C(O)C=1)S([O-])(=O)=O)S([O-])(=O)=O)=C1C=CC(=[N+](CC)CC)C=C1 RTMBGDBBDQKNNZ-UHFFFAOYSA-L 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 241000282472 Canis lupus familiaris Species 0.000 description 1
- 240000004160 Capsicum annuum Species 0.000 description 1
- 235000002568 Capsicum frutescens Nutrition 0.000 description 1
- 241000700198 Cavia Species 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- 235000008733 Citrus aurantifolia Nutrition 0.000 description 1
- 241001672694 Citrus reticulata Species 0.000 description 1
- 240000000560 Citrus x paradisi Species 0.000 description 1
- 235000013162 Cocos nucifera Nutrition 0.000 description 1
- 244000060011 Cocos nucifera Species 0.000 description 1
- 206010009900 Colitis ulcerative Diseases 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- 235000015655 Crocus sativus Nutrition 0.000 description 1
- 244000124209 Crocus sativus Species 0.000 description 1
- UDIPTWFVPPPURJ-UHFFFAOYSA-M Cyclamate Chemical compound [Na+].[O-]S(=O)(=O)NC1CCCCC1 UDIPTWFVPPPURJ-UHFFFAOYSA-M 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- LKDRXBCSQODPBY-JDJSBBGDSA-N D-allulose Chemical compound OCC1(O)OC[C@@H](O)[C@@H](O)[C@H]1O LKDRXBCSQODPBY-JDJSBBGDSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 206010012289 Dementia Diseases 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- GGLIEWRLXDLBBF-UHFFFAOYSA-N Dulcin Chemical compound CCOC1=CC=C(NC(N)=O)C=C1 GGLIEWRLXDLBBF-UHFFFAOYSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000283086 Equidae Species 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- YIKYNHJUKRTCJL-UHFFFAOYSA-N Ethyl maltol Chemical compound CCC=1OC=CC(=O)C=1O YIKYNHJUKRTCJL-UHFFFAOYSA-N 0.000 description 1
- 239000001329 FEMA 3811 Substances 0.000 description 1
- RZSYLLSAWYUBPE-UHFFFAOYSA-L Fast green FCF Chemical compound [Na+].[Na+].C=1C=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C(=CC(O)=CC=2)S([O-])(=O)=O)C=CC=1N(CC)CC1=CC=CC(S([O-])(=O)=O)=C1 RZSYLLSAWYUBPE-UHFFFAOYSA-L 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 235000016623 Fragaria vesca Nutrition 0.000 description 1
- 240000009088 Fragaria x ananassa Species 0.000 description 1
- 235000011363 Fragaria x ananassa Nutrition 0.000 description 1
- 229940123457 Free radical scavenger Drugs 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 244000194101 Ginkgo biloba Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 239000004378 Glycyrrhizin Substances 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 229920001908 Hydrogenated starch hydrolysate Polymers 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 229920001202 Inulin Polymers 0.000 description 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
- QAQJMLQRFWZOBN-LAUBAEHRSA-N L-ascorbyl-6-palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](O)[C@H]1OC(=O)C(O)=C1O QAQJMLQRFWZOBN-LAUBAEHRSA-N 0.000 description 1
- 239000011786 L-ascorbyl-6-palmitate Substances 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical class OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- COTIXRRJLCSLLS-PIJUOVFKSA-N Lipoyllysine Chemical compound OC(=O)[C@H](N)CCCCNC(=O)CCCCC1CCSS1 COTIXRRJLCSLLS-PIJUOVFKSA-N 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 1
- JEVVKJMRZMXFBT-XWDZUXABSA-N Lycophyll Natural products OC/C(=C/CC/C(=C\C=C\C(=C/C=C/C(=C\C=C\C=C(/C=C/C=C(\C=C\C=C(/CC/C=C(/CO)\C)\C)/C)\C)/C)\C)/C)/C JEVVKJMRZMXFBT-XWDZUXABSA-N 0.000 description 1
- 235000018330 Macadamia integrifolia Nutrition 0.000 description 1
- 235000003800 Macadamia tetraphylla Nutrition 0.000 description 1
- 240000000912 Macadamia tetraphylla Species 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 208000007466 Male Infertility Diseases 0.000 description 1
- 229920002774 Maltodextrin Polymers 0.000 description 1
- 239000005913 Maltodextrin Substances 0.000 description 1
- 241000220225 Malus Species 0.000 description 1
- 235000011430 Malus pumila Nutrition 0.000 description 1
- 235000015103 Malus silvestris Nutrition 0.000 description 1
- 240000003183 Manihot esculenta Species 0.000 description 1
- 235000016735 Manihot esculenta subsp esculenta Nutrition 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 241000276495 Melanogrammus aeglefinus Species 0.000 description 1
- 235000006679 Mentha X verticillata Nutrition 0.000 description 1
- 235000002899 Mentha suaveolens Nutrition 0.000 description 1
- 235000001636 Mentha x rotundifolia Nutrition 0.000 description 1
- 101710084933 Miraculin Proteins 0.000 description 1
- 108050004114 Monellin Proteins 0.000 description 1
- 240000005561 Musa balbisiana Species 0.000 description 1
- 235000018290 Musa x paradisiaca Nutrition 0.000 description 1
- 102000008934 Muscle Proteins Human genes 0.000 description 1
- 108010074084 Muscle Proteins Proteins 0.000 description 1
- 108010093901 N-(N-(3-(3-hydroxy-4-methoxyphenyl) propyl)-alpha-aspartyl)-L-phenylalanine 1-methyl ester Proteins 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- BAQMYDQNMFBZNA-UHFFFAOYSA-N N-biotinyl-L-lysine Natural products N1C(=O)NC2C(CCCCC(=O)NCCCCC(N)C(O)=O)SCC21 BAQMYDQNMFBZNA-UHFFFAOYSA-N 0.000 description 1
- BAWFJGJZGIEFAR-NNYOXOHSSA-N NAD zwitterion Chemical compound NC(=O)C1=CC=C[N+]([C@H]2[C@@H]([C@H](O)[C@@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 BAWFJGJZGIEFAR-NNYOXOHSSA-N 0.000 description 1
- XJLXINKUBYWONI-NNYOXOHSSA-O NADP(+) Chemical compound NC(=O)C1=CC=C[N+]([C@H]2[C@@H]([C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](OP(O)(O)=O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 XJLXINKUBYWONI-NNYOXOHSSA-O 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 239000004384 Neotame Substances 0.000 description 1
- NVNLLIYOARQCIX-MSHCCFNRSA-N Nisin Chemical compound N1C(=O)[C@@H](CC(C)C)NC(=O)C(=C)NC(=O)[C@@H]([C@H](C)CC)NC(=O)[C@@H](NC(=O)C(=C/C)/NC(=O)[C@H](N)[C@H](C)CC)CSC[C@@H]1C(=O)N[C@@H]1C(=O)N2CCC[C@@H]2C(=O)NCC(=O)N[C@@H](C(=O)N[C@H](CCCCN)C(=O)N[C@@H]2C(NCC(=O)N[C@H](C)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCSC)C(=O)NCC(=O)N[C@H](CS[C@@H]2C)C(=O)N[C@H](CC(N)=O)C(=O)N[C@H](CCSC)C(=O)N[C@H](CCCCN)C(=O)N[C@@H]2C(N[C@H](C)C(=O)N[C@@H]3C(=O)N[C@@H](C(N[C@H](CC=4NC=NC=4)C(=O)N[C@H](CS[C@@H]3C)C(=O)N[C@H](CO)C(=O)N[C@H]([C@H](C)CC)C(=O)N[C@H](CC=3NC=NC=3)C(=O)N[C@H](C(C)C)C(=O)NC(=C)C(=O)N[C@H](CCCCN)C(O)=O)=O)CS[C@@H]2C)=O)=O)CS[C@@H]1C NVNLLIYOARQCIX-MSHCCFNRSA-N 0.000 description 1
- 108010053775 Nisin Proteins 0.000 description 1
- QZOALWMSYRBZSA-UHFFFAOYSA-N Osladin Natural products C1CC(C)C(OC2C(C(O)C(O)C(C)O2)O)OC1C(C)C(C1(CCC2C3(C)CC4)C)CCC1C2CC(=O)C3CC4OC1OC(CO)C(O)C(O)C1OC1OC(C)C(O)C(O)C1O QZOALWMSYRBZSA-UHFFFAOYSA-N 0.000 description 1
- 229940123973 Oxygen scavenger Drugs 0.000 description 1
- 239000008124 P-4000 Substances 0.000 description 1
- 240000004371 Panax ginseng Species 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 101000865553 Pentadiplandra brazzeana Defensin-like protein Proteins 0.000 description 1
- 241000286209 Phasianidae Species 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 229920001100 Polydextrose Polymers 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 108010009736 Protein Hydrolysates Proteins 0.000 description 1
- 235000009827 Prunus armeniaca Nutrition 0.000 description 1
- 244000018633 Prunus armeniaca Species 0.000 description 1
- 235000006040 Prunus persica var persica Nutrition 0.000 description 1
- 235000014443 Pyrus communis Nutrition 0.000 description 1
- 240000001987 Pyrus communis Species 0.000 description 1
- 208000003782 Raynaud disease Diseases 0.000 description 1
- 208000012322 Raynaud phenomenon Diseases 0.000 description 1
- 240000001890 Ribes hudsonianum Species 0.000 description 1
- 235000016954 Ribes hudsonianum Nutrition 0.000 description 1
- 235000001466 Ribes nigrum Nutrition 0.000 description 1
- 244000178231 Rosmarinus officinalis Species 0.000 description 1
- 235000017848 Rubus fruticosus Nutrition 0.000 description 1
- 240000007651 Rubus glaucus Species 0.000 description 1
- 235000011034 Rubus glaucus Nutrition 0.000 description 1
- 235000009122 Rubus idaeus Nutrition 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 241001247145 Sebastes goodei Species 0.000 description 1
- 206010040867 Skin hypertrophy Diseases 0.000 description 1
- 239000004283 Sodium sorbate Substances 0.000 description 1
- 240000003768 Solanum lycopersicum Species 0.000 description 1
- 244000228451 Stevia rebaudiana Species 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-N Sulfurous acid Chemical class OS(O)=O LSNNMFCWUKXFEE-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 235000009470 Theobroma cacao Nutrition 0.000 description 1
- 240000006909 Tilia x europaea Species 0.000 description 1
- 235000011941 Tilia x europaea Nutrition 0.000 description 1
- 201000006704 Ulcerative Colitis Diseases 0.000 description 1
- 235000003095 Vaccinium corymbosum Nutrition 0.000 description 1
- 235000017537 Vaccinium myrtillus Nutrition 0.000 description 1
- 235000009499 Vanilla fragrans Nutrition 0.000 description 1
- 244000263375 Vanilla tahitensis Species 0.000 description 1
- 235000012036 Vanilla tahitensis Nutrition 0.000 description 1
- 229930003779 Vitamin B12 Natural products 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 229930003448 Vitamin K Natural products 0.000 description 1
- 208000021017 Weight Gain Diseases 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 235000010358 acesulfame potassium Nutrition 0.000 description 1
- 229960004998 acesulfame potassium Drugs 0.000 description 1
- 239000000619 acesulfame-K Substances 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 235000019453 advantame Nutrition 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- ANVAOWXLWRTKGA-XDECGSRTSA-N alfa-carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)C=CC1C(C)=CCCC1(C)C ANVAOWXLWRTKGA-XDECGSRTSA-N 0.000 description 1
- 150000001338 aliphatic hydrocarbons Chemical group 0.000 description 1
- 235000019409 alitame Nutrition 0.000 description 1
- 108010009985 alitame Proteins 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 239000006053 animal diet Substances 0.000 description 1
- 235000010385 ascorbyl palmitate Nutrition 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- 235000019413 aspartame-acesulfame salt Nutrition 0.000 description 1
- 235000013793 astaxanthin Nutrition 0.000 description 1
- 239000001168 astaxanthin Substances 0.000 description 1
- MQZIGYBFDRPAKN-UWFIBFSHSA-N astaxanthin Chemical compound C([C@H](O)C(=O)C=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)C(=O)[C@@H](O)CC1(C)C MQZIGYBFDRPAKN-UWFIBFSHSA-N 0.000 description 1
- MQZIGYBFDRPAKN-ZWAPEEGVSA-N astaxanthin Chemical compound C([C@H](O)C(=O)C=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)[C@@H](O)CC1(C)C MQZIGYBFDRPAKN-ZWAPEEGVSA-N 0.000 description 1
- 229940022405 astaxanthin Drugs 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 239000004176 azorubin Substances 0.000 description 1
- 235000012733 azorubine Nutrition 0.000 description 1
- 235000015191 beet juice Nutrition 0.000 description 1
- 235000012677 beetroot red Nutrition 0.000 description 1
- YNKMHABLMGIIFX-UHFFFAOYSA-N benzaldehyde;methane Chemical compound C.O=CC1=CC=CC=C1 YNKMHABLMGIIFX-UHFFFAOYSA-N 0.000 description 1
- 150000001558 benzoic acid derivatives Chemical class 0.000 description 1
- 235000021028 berry Nutrition 0.000 description 1
- 235000013735 beta-apo-8'-carotenal Nutrition 0.000 description 1
- 239000001652 beta-apo-8'-carotenal Substances 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 239000011127 biaxially oriented polypropylene Substances 0.000 description 1
- 229920006378 biaxially oriented polypropylene Polymers 0.000 description 1
- 239000003833 bile salt Substances 0.000 description 1
- 229940093761 bile salts Drugs 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- BAQMYDQNMFBZNA-MNXVOIDGSA-N biocytin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)NCCCC[C@H](N)C(O)=O)SC[C@@H]21 BAQMYDQNMFBZNA-MNXVOIDGSA-N 0.000 description 1
- 230000008827 biological function Effects 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 235000021029 blackberry Nutrition 0.000 description 1
- 235000021014 blueberries Nutrition 0.000 description 1
- 230000036995 brain health Effects 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 235000012745 brilliant blue FCF Nutrition 0.000 description 1
- 239000004161 brilliant blue FCF Substances 0.000 description 1
- 235000019282 butylated hydroxyanisole Nutrition 0.000 description 1
- 229940043253 butylated hydroxyanisole Drugs 0.000 description 1
- CZBZUDVBLSSABA-UHFFFAOYSA-N butylated hydroxyanisole Chemical compound COC1=CC=C(O)C(C(C)(C)C)=C1.COC1=CC=C(O)C=C1C(C)(C)C CZBZUDVBLSSABA-UHFFFAOYSA-N 0.000 description 1
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 1
- 229940095259 butylated hydroxytoluene Drugs 0.000 description 1
- GMRQFYUYWCNGIN-NKMMMXOESA-N calcitriol Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@@H](CCCC(C)(C)O)C)=C\C=C1\C[C@@H](O)C[C@H](O)C1=C GMRQFYUYWCNGIN-NKMMMXOESA-N 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000001511 capsicum annuum Substances 0.000 description 1
- 239000001325 capsicum annuum l. var. longum oleoresin Substances 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 235000013736 caramel Nutrition 0.000 description 1
- DGQLVPJVXFOQEV-JNVSTXMASA-N carminic acid Chemical compound OC1=C2C(=O)C=3C(C)=C(C(O)=O)C(O)=CC=3C(=O)C2=C(O)C(O)=C1[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O DGQLVPJVXFOQEV-JNVSTXMASA-N 0.000 description 1
- 150000001747 carotenoids Chemical group 0.000 description 1
- 235000013709 carrot oil Nutrition 0.000 description 1
- 235000020226 cashew nut Nutrition 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000005754 cellular signaling Effects 0.000 description 1
- 235000013351 cheese Nutrition 0.000 description 1
- OIQPTROHQCGFEF-UHFFFAOYSA-L chembl1371409 Chemical compound [Na+].[Na+].OC1=CC=C2C=C(S([O-])(=O)=O)C=CC2=C1N=NC1=CC=C(S([O-])(=O)=O)C=C1 OIQPTROHQCGFEF-UHFFFAOYSA-L 0.000 description 1
- CEZCCHQBSQPRMU-UHFFFAOYSA-L chembl174821 Chemical compound [Na+].[Na+].COC1=CC(S([O-])(=O)=O)=C(C)C=C1N=NC1=C(O)C=CC2=CC(S([O-])(=O)=O)=CC=C12 CEZCCHQBSQPRMU-UHFFFAOYSA-L 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 239000011651 chromium Substances 0.000 description 1
- 229940117916 cinnamic aldehyde Drugs 0.000 description 1
- KJPRLNWUNMBNBZ-UHFFFAOYSA-N cinnamic aldehyde Natural products O=CC=CC1=CC=CC=C1 KJPRLNWUNMBNBZ-UHFFFAOYSA-N 0.000 description 1
- 229940043350 citral Drugs 0.000 description 1
- AGVAZMGAQJOSFJ-WZHZPDAFSA-M cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].N#[C-].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O AGVAZMGAQJOSFJ-WZHZPDAFSA-M 0.000 description 1
- ZPUCINDJVBIVPJ-LJISPDSOSA-N cocaine Chemical compound O([C@H]1C[C@@H]2CC[C@@H](N2C)[C@H]1C(=O)OC)C(=O)C1=CC=CC=C1 ZPUCINDJVBIVPJ-LJISPDSOSA-N 0.000 description 1
- JBJSVEVEEGOEBZ-SCZZXKLOSA-N coenzyme B Chemical compound OP(=O)(O)O[C@H](C)[C@@H](C(O)=O)NC(=O)CCCCCCS JBJSVEVEEGOEBZ-SCZZXKLOSA-N 0.000 description 1
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 description 1
- 208000010877 cognitive disease Diseases 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000010411 cooking Methods 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 108010010165 curculin Proteins 0.000 description 1
- 229940109275 cyclamate Drugs 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 235000018823 dietary intake Nutrition 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- QGGZBXOADPVUPN-UHFFFAOYSA-N dihydrochalcone Chemical compound C=1C=CC=CC=1C(=O)CCC1=CC=CC=C1 QGGZBXOADPVUPN-UHFFFAOYSA-N 0.000 description 1
- PXLWOFBAEVGBOA-UHFFFAOYSA-N dihydrochalcone Natural products OC1C(O)C(O)C(CO)OC1C1=C(O)C=CC(C(=O)CC(O)C=2C=CC(O)=CC=2)=C1O PXLWOFBAEVGBOA-UHFFFAOYSA-N 0.000 description 1
- 239000008126 dulcin Substances 0.000 description 1
- NWNUTSZTAUGIGA-UHFFFAOYSA-N dulcin Natural products C12CC(C)(C)CCC2(C(=O)OC2C(C(O)C(O)C(COC3C(C(O)C(O)CO3)O)O2)O)C(O)CC(C2(CCC3C4(C)C)C)(C)C1=CCC2C3(C)CCC4OC1OCC(O)C(O)C1OC1OC(CO)C(O)C(O)C1O NWNUTSZTAUGIGA-UHFFFAOYSA-N 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- IINNWAYUJNWZRM-UHFFFAOYSA-L erythrosin B Chemical compound [Na+].[Na+].[O-]C(=O)C1=CC=CC=C1C1=C2C=C(I)C(=O)C(I)=C2OC2=C(I)C([O-])=C(I)C=C21 IINNWAYUJNWZRM-UHFFFAOYSA-L 0.000 description 1
- 235000012732 erythrosine Nutrition 0.000 description 1
- 239000004174 erythrosine Substances 0.000 description 1
- 229940011411 erythrosine Drugs 0.000 description 1
- 239000000686 essence Substances 0.000 description 1
- 235000004626 essential fatty acids Nutrition 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 1
- OPCRGEVPIBLWAY-QNRZBPGKSA-N ethyl (2E,4Z)-deca-2,4-dienoate Chemical compound CCCCC\C=C/C=C/C(=O)OCC OPCRGEVPIBLWAY-QNRZBPGKSA-N 0.000 description 1
- 229940093503 ethyl maltol Drugs 0.000 description 1
- 229940073505 ethyl vanillin Drugs 0.000 description 1
- 210000001508 eye Anatomy 0.000 description 1
- 235000019240 fast green FCF Nutrition 0.000 description 1
- 229940051147 fd&c yellow no. 6 Drugs 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 235000013924 ferrous gluconate Nutrition 0.000 description 1
- 239000004222 ferrous gluconate Substances 0.000 description 1
- 229960001645 ferrous gluconate Drugs 0.000 description 1
- 235000013925 ferrous lactate Nutrition 0.000 description 1
- 239000004225 ferrous lactate Substances 0.000 description 1
- 229940037907 ferrous lactate Drugs 0.000 description 1
- 229940013640 flavin mononucleotide Drugs 0.000 description 1
- 239000011768 flavin mononucleotide Substances 0.000 description 1
- FVTCRASFADXXNN-SCRDCRAPSA-N flavin mononucleotide Chemical compound OP(=O)(O)OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O FVTCRASFADXXNN-SCRDCRAPSA-N 0.000 description 1
- FVTCRASFADXXNN-UHFFFAOYSA-N flavin mononucleotide Natural products OP(=O)(O)OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O FVTCRASFADXXNN-UHFFFAOYSA-N 0.000 description 1
- 239000011888 foil Substances 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000013505 freshwater Substances 0.000 description 1
- FTSSQIKWUOOEGC-RULYVFMPSA-N fructooligosaccharide Chemical compound OC[C@H]1O[C@@](CO)(OC[C@@]2(OC[C@@]3(OC[C@@]4(OC[C@@]5(OC[C@@]6(OC[C@@]7(OC[C@@]8(OC[C@@]9(OC[C@@]%10(OC[C@@]%11(O[C@H]%12O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%12O)O[C@H](CO)[C@@H](O)[C@@H]%11O)O[C@H](CO)[C@@H](O)[C@@H]%10O)O[C@H](CO)[C@@H](O)[C@@H]9O)O[C@H](CO)[C@@H](O)[C@@H]8O)O[C@H](CO)[C@@H](O)[C@@H]7O)O[C@H](CO)[C@@H](O)[C@@H]6O)O[C@H](CO)[C@@H](O)[C@@H]5O)O[C@H](CO)[C@@H](O)[C@@H]4O)O[C@H](CO)[C@@H](O)[C@@H]3O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H]1O FTSSQIKWUOOEGC-RULYVFMPSA-N 0.000 description 1
- 229940107187 fructooligosaccharide Drugs 0.000 description 1
- 229960002737 fructose Drugs 0.000 description 1
- 239000008369 fruit flavor Substances 0.000 description 1
- 235000015203 fruit juice Nutrition 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 235000011087 fumaric acid Nutrition 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 235000004515 gallic acid Nutrition 0.000 description 1
- 229940074391 gallic acid Drugs 0.000 description 1
- 239000011663 gamma-carotene Substances 0.000 description 1
- 235000000633 gamma-carotene Nutrition 0.000 description 1
- HRQKOYFGHJYEFS-RZWPOVEWSA-N gamma-carotene Natural products C(=C\C=C\C(=C/C=C/C=C(\C=C\C=C(/C=C/C=1C(C)(C)CCCC=1C)\C)/C)\C)(\C=C\C=C(/CC/C=C(\C)/C)\C)/C HRQKOYFGHJYEFS-RZWPOVEWSA-N 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 239000008125 glucin Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229960001031 glucose Drugs 0.000 description 1
- 229960005150 glycerol Drugs 0.000 description 1
- 150000002332 glycine derivatives Chemical class 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 235000013756 grape colour extract Nutrition 0.000 description 1
- 235000012701 green S Nutrition 0.000 description 1
- 239000004120 green S Substances 0.000 description 1
- RQFCJASXJCIDSX-UUOKFMHZSA-N guanosine 5'-monophosphate Chemical class C1=2NC(N)=NC(=O)C=2N=CN1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O RQFCJASXJCIDSX-UUOKFMHZSA-N 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- 230000008821 health effect Effects 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- GFAZHVHNLUBROE-UHFFFAOYSA-N hydroxymethyl propionaldehyde Natural products CCC(=O)CO GFAZHVHNLUBROE-UHFFFAOYSA-N 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000007938 immune gene expression Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- KHLVKKOJDHCJMG-QDBORUFSSA-L indigo carmine Chemical compound [Na+].[Na+].N/1C2=CC=C(S([O-])(=O)=O)C=C2C(=O)C\1=C1/NC2=CC=C(S(=O)(=O)[O-])C=C2C1=O KHLVKKOJDHCJMG-QDBORUFSSA-L 0.000 description 1
- 235000012738 indigotine Nutrition 0.000 description 1
- 239000004179 indigotine Substances 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 235000021125 infant nutrition Nutrition 0.000 description 1
- 208000000509 infertility Diseases 0.000 description 1
- 230000036512 infertility Effects 0.000 description 1
- 231100000535 infertility Toxicity 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 229940029339 inulin Drugs 0.000 description 1
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 description 1
- 229960004903 invert sugar Drugs 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- VRIVJOXICYMTAG-IYEMJOQQSA-L iron(ii) gluconate Chemical compound [Fe+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O VRIVJOXICYMTAG-IYEMJOQQSA-L 0.000 description 1
- 229940117955 isoamyl acetate Drugs 0.000 description 1
- 239000000905 isomalt Substances 0.000 description 1
- 235000010439 isomalt Nutrition 0.000 description 1
- HPIGCVXMBGOWTF-UHFFFAOYSA-N isomaltol Natural products CC(=O)C=1OC=CC=1O HPIGCVXMBGOWTF-UHFFFAOYSA-N 0.000 description 1
- DLRVVLDZNNYCBX-RTPHMHGBSA-N isomaltose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)C(O)O1 DLRVVLDZNNYCBX-RTPHMHGBSA-N 0.000 description 1
- BJHIKXHVCXFQLS-PQLUHFTBSA-N keto-D-tagatose Chemical compound OC[C@@H](O)[C@H](O)[C@H](O)C(=O)CO BJHIKXHVCXFQLS-PQLUHFTBSA-N 0.000 description 1
- 229940106134 krill oil Drugs 0.000 description 1
- 229960000448 lactic acid Drugs 0.000 description 1
- 239000000832 lactitol Substances 0.000 description 1
- 235000010448 lactitol Nutrition 0.000 description 1
- VQHSOMBJVWLPSR-JVCRWLNRSA-N lactitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-JVCRWLNRSA-N 0.000 description 1
- 229960003451 lactitol Drugs 0.000 description 1
- 239000004571 lime Substances 0.000 description 1
- 229940087305 limonene Drugs 0.000 description 1
- 235000001510 limonene Nutrition 0.000 description 1
- 235000019136 lipoic acid Nutrition 0.000 description 1
- AGBQKNBQESQNJD-UHFFFAOYSA-N lipoic acid Chemical compound OC(=O)CCCCC1CCSS1 AGBQKNBQESQNJD-UHFFFAOYSA-N 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 235000012661 lycopene Nutrition 0.000 description 1
- 239000001751 lycopene Substances 0.000 description 1
- 229960004999 lycopene Drugs 0.000 description 1
- OAIJSZIZWZSQBC-GYZMGTAESA-N lycopene Chemical compound CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCC=C(C)C OAIJSZIZWZSQBC-GYZMGTAESA-N 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000010449 maltitol Nutrition 0.000 description 1
- 239000000845 maltitol Substances 0.000 description 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 1
- 229940035436 maltitol Drugs 0.000 description 1
- 229940035034 maltodextrin Drugs 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 229960001855 mannitol Drugs 0.000 description 1
- 230000008774 maternal effect Effects 0.000 description 1
- 235000013622 meat product Nutrition 0.000 description 1
- 210000004379 membrane Anatomy 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000015654 memory Effects 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 235000006109 methionine Nutrition 0.000 description 1
- 229940102398 methyl anthranilate Drugs 0.000 description 1
- 229960001047 methyl salicylate Drugs 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 235000020166 milkshake Nutrition 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 229930189775 mogroside Natural products 0.000 description 1
- 230000036651 mood Effects 0.000 description 1
- 229950006238 nadide Drugs 0.000 description 1
- ITVGXXMINPYUHD-CUVHLRMHSA-N neohesperidin dihydrochalcone Chemical compound C1=C(O)C(OC)=CC=C1CCC(=O)C(C(=C1)O)=C(O)C=C1O[C@H]1[C@H](O[C@H]2[C@@H]([C@H](O)[C@@H](O)[C@H](C)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 ITVGXXMINPYUHD-CUVHLRMHSA-N 0.000 description 1
- 229940089953 neohesperidin dihydrochalcone Drugs 0.000 description 1
- 235000010434 neohesperidine DC Nutrition 0.000 description 1
- 235000019412 neotame Nutrition 0.000 description 1
- HLIAVLHNDJUHFG-HOTGVXAUSA-N neotame Chemical compound CC(C)(C)CCN[C@@H](CC(O)=O)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 HLIAVLHNDJUHFG-HOTGVXAUSA-N 0.000 description 1
- 108010070257 neotame Proteins 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 230000004770 neurodegeneration Effects 0.000 description 1
- 208000015122 neurodegenerative disease Diseases 0.000 description 1
- 230000004776 neurological deficiency Effects 0.000 description 1
- 230000000926 neurological effect Effects 0.000 description 1
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 description 1
- 239000004309 nisin Substances 0.000 description 1
- 235000010297 nisin Nutrition 0.000 description 1
- 150000002823 nitrates Chemical class 0.000 description 1
- 150000002826 nitrites Chemical class 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 239000012299 nitrogen atmosphere Substances 0.000 description 1
- GYHFUZHODSMOHU-UHFFFAOYSA-N nonanal Chemical compound CCCCCCCCC=O GYHFUZHODSMOHU-UHFFFAOYSA-N 0.000 description 1
- 235000021436 nutraceutical agent Nutrition 0.000 description 1
- NUJGJRNETVAIRJ-UHFFFAOYSA-N octanal Chemical compound CCCCCCCC=O NUJGJRNETVAIRJ-UHFFFAOYSA-N 0.000 description 1
- 239000008601 oleoresin Substances 0.000 description 1
- 210000001672 ovary Anatomy 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 230000036542 oxidative stress Effects 0.000 description 1
- 229940094443 oxytocics prostaglandins Drugs 0.000 description 1
- 230000020477 pH reduction Effects 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- 235000012658 paprika extract Nutrition 0.000 description 1
- DYUUPIKEWLHQGQ-SDXBLLFJSA-N paprika oleoresin Chemical compound C(\[C@]12[C@@](O1)(C)C[C@@H](O)CC2(C)C)=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=C[C@H]1C(C)=C[C@H](O)CC1(C)C DYUUPIKEWLHQGQ-SDXBLLFJSA-N 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 235000011007 phosphoric acid Nutrition 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 239000001259 polydextrose Substances 0.000 description 1
- 235000013856 polydextrose Nutrition 0.000 description 1
- 229940035035 polydextrose Drugs 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 229920001592 potato starch Polymers 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 244000144977 poultry Species 0.000 description 1
- 235000013594 poultry meat Nutrition 0.000 description 1
- 235000013613 poultry product Nutrition 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- 229940095574 propionic acid Drugs 0.000 description 1
- 150000003180 prostaglandins Chemical class 0.000 description 1
- 238000001243 protein synthesis Methods 0.000 description 1
- 235000007682 pyridoxal 5'-phosphate Nutrition 0.000 description 1
- 239000011589 pyridoxal 5'-phosphate Substances 0.000 description 1
- 229960001327 pyridoxal phosphate Drugs 0.000 description 1
- 235000008160 pyridoxine Nutrition 0.000 description 1
- 239000011677 pyridoxine Substances 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 229940051201 quinoline yellow Drugs 0.000 description 1
- IZMJMCDDWKSTTK-UHFFFAOYSA-N quinoline yellow Chemical compound C1=CC=CC2=NC(C3C(C4=CC=CC=C4C3=O)=O)=CC=C21 IZMJMCDDWKSTTK-UHFFFAOYSA-N 0.000 description 1
- 239000002516 radical scavenger Substances 0.000 description 1
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 235000019172 retinyl palmitate Nutrition 0.000 description 1
- 239000011769 retinyl palmitate Substances 0.000 description 1
- 229940108325 retinyl palmitate Drugs 0.000 description 1
- 206010039073 rheumatoid arthritis Diseases 0.000 description 1
- 235000019231 riboflavin-5'-phosphate Nutrition 0.000 description 1
- 235000013974 saffron Nutrition 0.000 description 1
- 239000004248 saffron Substances 0.000 description 1
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical class OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 235000015067 sauces Nutrition 0.000 description 1
- 235000013580 sausages Nutrition 0.000 description 1
- 235000014102 seafood Nutrition 0.000 description 1
- 235000015170 shellfish Nutrition 0.000 description 1
- 235000013570 smoothie Nutrition 0.000 description 1
- 235000010378 sodium ascorbate Nutrition 0.000 description 1
- PPASLZSBLFJQEF-RKJRWTFHSA-M sodium ascorbate Substances [Na+].OC[C@@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RKJRWTFHSA-M 0.000 description 1
- 229960005055 sodium ascorbate Drugs 0.000 description 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
- 235000010234 sodium benzoate Nutrition 0.000 description 1
- 239000004299 sodium benzoate Substances 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- 235000011083 sodium citrates Nutrition 0.000 description 1
- 229960001462 sodium cyclamate Drugs 0.000 description 1
- FZHLWVUAICIIPW-UHFFFAOYSA-M sodium gallate Chemical compound [Na+].OC1=CC(C([O-])=O)=CC(O)=C1O FZHLWVUAICIIPW-UHFFFAOYSA-M 0.000 description 1
- JXKPEJDQGNYQSM-UHFFFAOYSA-M sodium propionate Chemical compound [Na+].CCC([O-])=O JXKPEJDQGNYQSM-UHFFFAOYSA-M 0.000 description 1
- 235000010334 sodium propionate Nutrition 0.000 description 1
- 239000004324 sodium propionate Substances 0.000 description 1
- 229960003212 sodium propionate Drugs 0.000 description 1
- LROWVYNUWKVTCU-STWYSWDKSA-M sodium sorbate Chemical compound [Na+].C\C=C\C=C\C([O-])=O LROWVYNUWKVTCU-STWYSWDKSA-M 0.000 description 1
- 235000019250 sodium sorbate Nutrition 0.000 description 1
- PPASLZSBLFJQEF-RXSVEWSESA-M sodium-L-ascorbate Chemical compound [Na+].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RXSVEWSESA-M 0.000 description 1
- 235000014214 soft drink Nutrition 0.000 description 1
- 235000010199 sorbic acid Nutrition 0.000 description 1
- 239000004334 sorbic acid Substances 0.000 description 1
- 229940075582 sorbic acid Drugs 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 235000003724 spirulina extract Nutrition 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 238000010025 steaming Methods 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000005846 sugar alcohols Chemical class 0.000 description 1
- 230000009469 supplementation Effects 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 235000010436 thaumatin Nutrition 0.000 description 1
- 239000000892 thaumatin Substances 0.000 description 1
- 235000019157 thiamine Nutrition 0.000 description 1
- 239000011721 thiamine Substances 0.000 description 1
- 229960002663 thioctic acid Drugs 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 125000002640 tocopherol group Chemical class 0.000 description 1
- 235000019149 tocopherols Nutrition 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- ZCIHMQAPACOQHT-ZGMPDRQDSA-N trans-isorenieratene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/c1c(C)ccc(C)c1C)C=CC=C(/C)C=Cc2c(C)ccc(C)c2C ZCIHMQAPACOQHT-ZGMPDRQDSA-N 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- HRXKRNGNAMMEHJ-UHFFFAOYSA-K trisodium citrate Chemical class [Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O HRXKRNGNAMMEHJ-UHFFFAOYSA-K 0.000 description 1
- UJMBCXLDXJUMFB-UHFFFAOYSA-K trisodium;5-oxo-1-(4-sulfonatophenyl)-4-[(4-sulfonatophenyl)diazenyl]-4h-pyrazole-3-carboxylate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)C1=NN(C=2C=CC(=CC=2)S([O-])(=O)=O)C(=O)C1N=NC1=CC=C(S([O-])(=O)=O)C=C1 UJMBCXLDXJUMFB-UHFFFAOYSA-K 0.000 description 1
- SWGJCIMEBVHMTA-UHFFFAOYSA-K trisodium;6-oxido-4-sulfo-5-[(4-sulfonatonaphthalen-1-yl)diazenyl]naphthalene-2-sulfonate Chemical compound [Na+].[Na+].[Na+].C1=CC=C2C(N=NC3=C4C(=CC(=CC4=CC=C3O)S([O-])(=O)=O)S([O-])(=O)=O)=CC=C(S([O-])(=O)=O)C2=C1 SWGJCIMEBVHMTA-UHFFFAOYSA-K 0.000 description 1
- 238000001291 vacuum drying Methods 0.000 description 1
- 235000015192 vegetable juice Nutrition 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000019163 vitamin B12 Nutrition 0.000 description 1
- 239000011715 vitamin B12 Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 235000019168 vitamin K Nutrition 0.000 description 1
- 239000011712 vitamin K Substances 0.000 description 1
- 150000003721 vitamin K derivatives Chemical class 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 229940046010 vitamin k Drugs 0.000 description 1
- 230000004584 weight gain Effects 0.000 description 1
- 235000019786 weight gain Nutrition 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- 235000013618 yogurt Nutrition 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L17/00—Food-from-the-sea products; Fish products; Fish meal; Fish-egg substitutes; Preparation or treatment thereof
- A23L17/10—Fish meal or powder; Granules, agglomerates or flakes
-
- A—HUMAN NECESSITIES
- A21—BAKING; EDIBLE DOUGHS
- A21D—TREATMENT OF FLOUR OR DOUGH FOR BAKING, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS
- A21D2/00—Treatment of flour or dough by adding materials thereto before or during baking
- A21D2/08—Treatment of flour or dough by adding materials thereto before or during baking by adding organic substances
- A21D2/24—Organic nitrogen compounds
- A21D2/26—Proteins
- A21D2/261—Animal proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23B—PRESERVATION OF FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES; CHEMICAL RIPENING OF FRUIT OR VEGETABLES
- A23B2/00—Preservation of foods or foodstuffs, in general
- A23B2/90—Preservation of foods or foodstuffs, in general by drying or kilning; Subsequent reconstitution
- A23B2/93—Spray drying
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
- A23J1/00—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites
- A23J1/04—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites from fish or other sea animals
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L17/00—Food-from-the-sea products; Fish products; Fish meal; Fish-egg substitutes; Preparation or treatment thereof
- A23L17/30—Fish eggs, e.g. caviar; Fish-egg substitutes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
- C07K14/43509—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from crustaceans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/461—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from fish
Definitions
- composition comprising spray dried roe
- the present invention relates to compositions such as dietary supplements, nutritional supplements, food products and pharmaceutical compositions, comprising spray dried roe, wherein the spray dried roe is in the form of a powder and comprises less than 10 wt% water.
- the present invention also relates to the spray dried roe per se and to a process for preparing the spray dried roe.
- the invention further relates to a package (e.g. pouch, bottle, and canister) containing the composition or spray dried roe.
- omega-3 fatty acids come from marine sources: eicosapentaenoic acid (EPA), docosapentaenoic acid (DPA) and docosahexaenoic acid (DHA). These fatty acids help facilitate important immune functions, gene expression and platelet aggregation, and also help maintain membrane fluidity and structure, cell signalling pathways, and synthesis of physiologically important chemicals such as prostaglandins. Long chain omega-3 fatty acids are also known for their ability to reduce inflammation.
- EPA eicosapentaenoic acid
- DPA docosapentaenoic acid
- DHA docosahexaenoic acid
- PUFAs Polyunsaturated fatty acids
- EPA eicosapentaenoic acid
- DHA docosahexaenoic acid
- n-3 PUFA Today, various governments and health organizations recommend dietary intakes for total n-3 PUFA of 1 .4 to 2.5 g/d, with EPA plus DHA ranging from 140 to 600 mg/d. Unfortunately, in many western countries, these recommendations are not met by the majority of people. Therefore, other dietary sources of EPA and DHA are being sought. Food enrichment may be the best long-term solution to boost intake of long chain n-3 PUFA.
- omega-3 fatty acids In light of recent consumer demand for food products containing healthier oils, manufacturers have introduced several foods fortified with omega-3 fatty acids.
- the main categories of foods being fortified with omega- 3s are dairy products, nutritional beverages and baked goods.
- the chief sources of EPA and DHA are fish oils or purified preparations from microalgae, which when added to foods, impart a fishy flavour that is considered unacceptable.
- omega-6 omega 3 fatty acids
- Many food manufacturers are in the process of reformulating their food products towards healthier compositions.
- Numerous studies have demonstrated that omega-3 fatty acids have positive effects on preventing or curing diseases like heart disease, cancer, rheumatoid arthritis, diabetes, ulcerative colitis, Raynaud's disease, allergies, eczema, skin thickening, weight gain and a host of other diseases.
- the present invention provides a composition comprising spray dried roe, wherein said spray dried roe is in the form of a powder and comprises less than 10 wt% water, based on the total weight of the spray dried roe.
- the present invention provides spray dried roe in the form of a powder, wherein said spray dried roe comprises less than 10 wt% water, based on the total weight of the spray dried roe.
- the present invention provides a process for preparing spray-dried roe as hereinbefore defined, comprising:
- the present invention provides a package containing spray dried roe as hereinbefore defined.
- spray drying refers to a method of producing a dry powder from a liquid or slurry by rapidly drying with a gas.
- a liquid or slurry is dispersed by an atomiser or spray nozzle into droplets and hot gas is blown into the droplets to evaporate the liquid therefrom.
- hot gas is blown into the droplets to evaporate the liquid therefrom.
- spray drying does not include freeze drying (lyophilisation) or vacuum drying.
- spray dried refers to a product obtained from a spray drying process.
- the term“roe” refers to the eggs of fish. The term encompasses both unripe and ripe eggs taken from the ovaries of fish.
- the outer surface of an egg consists of a coating that acts as a solid shield (the chorion and vitelline membrane) that protects the interior.
- powder refers to an assembly of solid particles. Powders may be characterised by the size of the particles in the assembly. When the term“particle size” is used herein, the average diameter of particles is meant. Particle size may be determined, for example, by laser diffraction.
- fatty acid refers to a carboxylic acid or a carboxylic acid moiety (i.e. the carboxylic acid without the acid hydrogen) with an aliphatic hydrocarbon chain which may be saturated or unsaturated. Typically the hydrocarbon chain comprises 6-22 carbon atoms.
- omega-3 fatty acid refers to a polyunsaturated fatty acid (PUFA) that has the first double bond in the hydrocarbon chain, when viewed from the free end of the hydrocarbon chain (i.e. the end furthest from the carboxylic acid group), between the third and fourth carbon atoms from the free end of the hydrocarbon chain.
- PUFA polyunsaturated fatty acid
- omega-6 fatty acid refers to a polyunsaturated fatty acid that has the first double bond in the hydrocarbon chain, when viewed from the free end of the hydrocarbon chain (i.e. the end furthest from the carboxylic acid group), between the sixth and seventh carbon atoms from the free end of the hydrocarbon chain.
- dietary supplement refers to a product intended for ingestion, alongside a human or animal diet, that provides nutrients that the human or animal might otherwise not consume in sufficient quantities (e.g. through their regular diet). Typically a dietary supplement does not contain a significant amount of calories.
- nutritional supplement refers to a product intended for ingestion by a human or animal that provides nutrients that the human or animal might otherwise not consume in sufficient quantities (e.g. through their regular diet) as well as a source of calories.
- nutritional supplements include meal replacements, nutritional drinks and energy bars.
- sports supplement refers to a nutritional supplement specifically designed to provide nutrients to enhance or improve a person’s performance during sport or exercise, their recovery following sport or exercise and/or the effects of sport or exercise on them.
- “food product” refers to any substance that is intended to be consumed by a human or animal.
- the term encompasses products that are themselves food products as well as ingredients of such products, i.e. products, which after combination with other ingredients, are food products.
- the present invention provides a composition comprising spray dried roe, wherein the spray dried roe is in the form of a powder and comprises less than 10 %wt water.
- Roe is an extremely attractive ingredient for use in, e.g. food and health products, in light of its ideal balance of ingredients and in particular its omega 6 to omega 3 fatty acid ratio.
- the problem with roe is that it has low storage stability and has a strong fishy smell and flavour which is often undesirable.
- compositions of the invention comprising spray dried roe provide therapeutic and/or nutritional benefits to animals, including human and non-human animals.
- non-human animals include dogs, cats, chickens, turkeys, horses, sheep, cows, pigs, guinea pigs and fish.
- domestic animals, e.g. pets, are one preferred group of non-human animals.
- the therapeutic and/or nutritional benefit is achieved as a result of the composition of the spray dried roe.
- Examples of neurological conditions that may be improved, maintained or treated by the compositions of the invention include dementia, cognitive dysfunction, DHA or neurological deficiencies, overall brain health, mood, memory and concentration, brain and retina cell survival during both aging and the initiation and progression of neurodegenerative diseases, digestive and/or fat absorption issues.
- the compositions of the present invention can also improve, maintain or treat infertility, particularly male infertility.
- the composition is a dietary supplement, a nutritional supplement, a food product or a pharmaceutical composition.
- the composition is a food product.
- the food product may be a human food or an animal food. Particularly preferably the food is an animal food, e.g. pet food.
- the pet food may be dry feed or wet feed.
- the product may be any conventional food type.
- Representative examples include animal feed (e.g. pet food, aquaculture feed), infant formula feed, baby food, food for children and youngsters, drinks (e.g. milk, milk shake, soft drink, juice, smoothie etc.), baked goods (e.g. bread), meat or fish products (e.g. burgers, sausages, fish cakes, crab sticks, etc.), sports products, snack foods (e.g. chocolate bars), sauces, soups, toppings or dressings, dairy products (e.g. yoghurts, cheese), pregnancy nutrition food products and frozen meals.
- animal feed e.g. pet food, aquaculture feed
- infant formula feed e.g. baby food, food for children and youngsters
- drinks e.g. milk, milk shake, soft drink, juice, smoothie etc.
- baked goods e.g. bread
- meat or fish products e.g. burgers, sausages, fish cakes, crab sticks, etc.
- sports products e.g. chocolate bars
- Preferred food products of the present invention comprise spray dried roe as herein defined in an amount of 0.5 wt% to 50 wt%, more preferably 1 wt% to 40 wt%, yet more preferably 1 wt% to 20 wt%, and still more preferably 1 wt% to 10 wt%, based on the total weight of the food product.
- the food product of the present invention comprises spray dried roe as hereinbefore defined in an amount of 1 wt% to 5 wt%, based on the total weight of the food product.
- the composition of the invention when the composition of the invention is a dietary supplement, the supplement may be in any conventional form.
- suitable forms include pills, powders, drinks or bars.
- the dietary supplement is in a form suitable for ingestion.
- Preferred dietary supplements of the present invention comprise spray dried roe as herein defined in an amount of 1 wt% to 80 wt%, more preferably 5 wt% to 70 wt%, yet more preferably 10 wt% to 60 wt%, and still more preferably 15 wt% to 50 wt%, based on the total weight of the dietary supplement.
- Preferred dietary supplements further comprise one or more nutraceutical agents.
- suitable agents include thiamin, riboflavin, nicotinic add pantothenic acid, pyridoxine, biotin, folic acid, vitamin B12, lipoic acid, ascorbic acid, vitamin A, vitamin D, vitamin E, vitamin K, thiamine pyrophosphates (TPP), flavin mononucleotide (FMM), flavin adenine dinucleotide (FAD), Nicotinamide adenine dinucleotide, nicotinamide adenine dinucleotide phosphate (NADP), coenzyme A (CoA), coenzyme Q10 (CoQ10), pyridoxal phosphate, biocytin, tetrahydrofolic acid, coenzyme B 12, lipoyllysine, 1 1 -cis-retinal, 25-dihydroxychole
- suitable agents include thiamin, rib
- the supplement may be in any conventional form.
- the nutritional supplement of the present invention is in the form of food, e.g. a meal, a snack or a drink.
- Preferred nutritional supplements of the present invention further comprise carbohydrate, protein, fat and mixtures thereof. Conventional sources of carbohydrate, protein and fat may be used.
- Preferred nutritional supplements of the present invention comprise spray dried roe as herein defined in an amount of 0.5 wt% to 50 wt%, more preferably 1 wt% to 40 wt%, yet more preferably 1 wt% to 20 wt%, and still more preferably 1 wt% to 10 wt%, based on the total weight of the nutritional supplement.
- compositions and particularly preferred dietary supplements, nutritional supplements and food products, further comprise one or more further substances.
- the preferred further substances depend on the type of the composition. Generally, however, the one or more further substances are selected from flavourings, sweeteners, minerals, binders, smell modifiers, fillers, surfactants, preservatives, colourings, antioxidants, sorbents and mixtures thereof.
- Antioxidants are a particularly preferred further substance.
- compositions comprise one or more antioxidants.
- Preferred antioxidants are selected from rosemary, vitamin E, astaxanthine, carnitine, ascorbyl palmitate, spermine, curcumin and mixtures thereof, more preferably curcumin and spermine and mixtures thereof and still more preferably circumin.
- Particularly preferred compositions comprise curcumin in an amount from 10 to 500 mg curcumin/100 g of the composition, more preferably in an amount from 50 to 250 mg curcumin/100 g of the composition and still more preferably in an amount from 100 to 200 mg curcumin/100 g of the composition.
- the addition of antioxidants e.g. curcumin
- a significant advantage of the spray dried roe of the present invention is its oxidation and flavour stability. Without wishing to be bound by theory, this is thought to be due to the largely intact structure achieved by the spray drying process and the naturally high content of antioxidants, which are optionally supplemented.
- compositions of the present invention further comprise flavourings, and preferably comprise flavourings selected from volatile oils, synthetic flavor oils, flavoring aromatics, oils, liquids, oleoresins and extracts derived from plants leaves, flowers, fruits, citric oils, lemon, orange, grape, lime and grape fruit, fruit essences including apple, pear, peach, banana, grape, berry, strawberry, raspberry, blueberry, blackberry, cherry, plum, pineapple, apricot, other fruit flavors such as aldehydes and esters, benzaldehyde (cherry almond), citral, alpha-central (lemon lime), neral, beta-citral (lemon lime), decanal (orange lemon), aldehyde C-8 (citrus fruits), aldehyde C-9 (citrus fruits), aldehyde C-12 (citrus fruits), tolyl aldehyde (cherry almond), 2,6-dimethyloctanal (green fruit), 2-dodedenal (citrus mandarin
- compositions of the present invention further comprise sweeteners.
- Preferred sweeteners are selected from glucose, invert sugar, fructose, saccharin and its various salts, cyclamic acid and its various salts, aspartame, dihydrochalcone, sugar alcohols including sorbitol syrup, luo han, cyclamate, saccharin, sucralose, mogorosides, brazzein, curculin, erythritol, fructooligosaccharide, glycyrrhizin, glycerol, hydrogenated starch hydrolysates, inulin, isomalt, isomaltooligosaccharide, isomaltulose, lactitol, mogroside mix, mabinlin, maltitol, maltodextrin, mannitol, miraculin, monatin, monellin, osladin, pentadin, polydextrose, psicose, sorbitol
- compositions of the present invention further comprise minerals.
- Preferred minerals are selected from calcium, iron, zinc, selenium, copper, iodine, magnesium, phosphorus and chromium
- compositions of the present invention further comprise preservatives.
- Preferred preservatives are selected from organic acid salts, vitamins, essential oils, sorbic acid, sorbates, sodium sorbate, benzoic acid, benzoates, sodium benzoate, benzoic acid, hydroxybenzoates, sulfur dioxide, sulphites, nitrites, nitrates, lactic acid, propionic acid, sodium propionate, ascorbic acid, sodium ascorbate, butylated hydroxytoluene, butylated hydroxyanisole, gallic acid, sodium gallate, tocopherols, vitamin A, vitamin E, vitamin C, retinyl palmitate, selenium, amino acids including cysteine and methionine, citric acid, sodium citrates, acetic acid, hydrogen peroxide and nisin.
- Suitable preservative processes include fermentation, margination, and acidification.
- compositions of the present invention further comprise colourings.
- Preferred colourings are selected from natural colourings and artificial colourings such as E104 (Quinoline yellow), E122 (carrmoisine), E124 (ponceau 4R), E131 (Patent Blue V), E142 (Green S), FD&C Blue No. 1 , FD&C Blue No.2, FD&C Green No. 3, FD&C Red No.3, FD&C Red No.
- compositions of the present invention comprise binders.
- Preferred binders are selected from potato starch, flour, eggs and tapioca flour.
- compositions of the present invention comprise sorbents.
- Particularly suitable sorbents include free-radical scavengers and oxygen scavengers.
- compositions of the present invention comprise smell modifiers. Any suitable conventional smell modifiers may be used.
- compositions of the present invention comprise surfactants. Any suitable conventional surfactants may be used.
- compositions of the present invention comprise fillers. Any suitable conventional fillers may be used.
- the present invention provides spray dried roe in the form of a powder.
- the powder is dry powder.
- the powder is a dehydrated powder.
- the powder is free flowing and can therefore be handled and manipulated without the particles comprising the powder sticking together.
- the spray dried roe of the present invention advantageously contains all the desirable nutritional components of fresh roe in a form with an attractive texture and flavour profile and good stability (e.g. to oxidation).
- Roe has an ideally balanced and highly attractive nutritional profile with high amounts of phospholipids, predominantly phosphatidylcholine, with a very high percentage of omega-3 long chain polyunsaturated fatty acids, potent lipophilic antioxidants with carotenoid structures (e.g. astaxanthin, canthaxanthin) and a large portion of protein with an attractive amino acid profile.
- the spray dried roe of the present invention is highly advantageous in that it comprises the same ideal balance of ingredients as fresh roe but may be stably stored for longer periods of time.
- the spray drying process employed in the present invention does not cause oxidation, e.g. of the lipids, does not induce the generation of smelly amines, and does not destroy the overall composition of the fresh roe.
- the spray dried roe of the present invention comprises less than 10 wt% water, based on the total weight of the spray dried roe.
- the spray dried roe comprises less than 8 wt% water, more preferably less than 7 wt% water and still more preferably less than 6 wt% water, based on the total weight of the spray dried roe.
- the spray dried roe comprises less than 5 wt% water, based on the total weight of the spray dried roe.
- the minimum amount of water may be, for example, 0.5 or 0.1 wt%, based on the total weight of the spray dried roe.
- the spray dried roe of the invention comprises all the components of fresh roe minus the majority, e.g. all, of the water.
- the spray dried roe provides the nutrients of fresh roe but in a form which is stable, lightweight, easy to store and transport, and suitable for use in many compositions and applications.
- the spray dried roe of the present invention comprises at least 90 wt% ingredients derived from fresh roe, based on the total weight of the spray dried roe.
- the spray dried roe of the present invention comprises at least 92 wt%, still more preferably at least 93 wt% and yet more preferably at least 94 wt% ingredients derived from fresh roe, based on the total weight of the spray dried roe.
- the spray dried roe of the present invention comprises at least 95 wt% ingredients derived from fresh roe, based on the total weight of the spray dried roe.
- the maximum amount of ingredients derived from fresh roe may be 100 wt%, based on the total weight of the spray dried roe.
- the spray dried roe consists essentially of, e.g.
- composition of the spray dried roe of the present invention is substantially the same as, e.g. is the same as, the composition of the fresh roe from which the spray dried roe is derived, except for the water content.
- the spray dried roe of the present invention is preferably non-encapsulated.
- Encapsulation is often used when formulating fish oils to improve their solubility and/or bioavailability.
- Encapsulation (e.g. microencapsulation) materials generally have no nutritional value and can make up a significant weight proportion of an encapsulated product.
- encapsulation (e.g. microencapsulation) of marine extracts that contain a high level of phospholipids can lead to an undesirable rubberlike appearance and/or texture.
- the spray dried roe of the present invention provides a free flowing powder and does not require encapsulation.
- the spray dried roe of the present invention is in the form of a powder, preferably a free flowing powder.
- the spray dried roe has a particle size (e.g. an average diameter) of less than 400 pm, more preferably less than 300 pm, and still more preferably less than 250 pm (e.g. less than 200 pm).
- the spray dried roe has a particle size (e.g. an average diameter) of greater than 20 pm, more preferably greater than 40 pm, and still more preferably greater than 50 pm (e.g. greater than 75 pm).
- the spray dried roe of the present invention has a particle size (e.g.
- the spray dried roe has a particle size (e.g. an average diameter) of 75 pm to 125 pm, more preferably about 100 pm.
- the spray dried roe may have a preferred particle size of 1 to 50 pm, more preferably 5 to 25 pm and still more preferably about 10 pm.
- the spray dried roe of the present invention may be derived from various marine species, e.g. fish or shellfish.
- the spray dried roe may be derived from saltwater or freshwater species.
- the roe is selected from capelin roe, cod roe, herring roe, saithe roe, shrimp roe or salmon roe, preferably capelin roe, cod roe, herring roe or salmon roe, more preferably herring roe.
- Herring roe is particularly preferred as it provides an ideal balance of nutritional properties.
- the spray dried roe of the present invention may be derived from unripe roe or ripe roe.
- the spray dried roe of the present invention preferably comprises a large proportion of protein.
- the spray dried roe comprises 60 wt% to 90 wt%, more preferably 65 wt% to 85 wt% and still more preferably 70 to 80 wt% of protein based on the total weight of the spray dried roe.
- the spray dried roe preferably comprises 60 wt% to 80 wt%, more preferably 65 wt% to 75 wt% of protein based on the total weight of the spray dried roe.
- all of the protein present in the spray dried roe is derived from the roe per se, i.e. no external protein is added.
- the proteins, peptides and polypeptides (e.g. proteins) in the spray dried roe of the present invention are in their original configuration (i.e. they are in the same configuration as they were in in the fresh roe from which the spray dried roe is derived).
- the proteins are not denatured or degraded, e.g. by hydrolytic processes, relative to their configuration in the fresh roe.
- 80 to 100 wt%, more preferably 90 to 100 wt%, still more preferably 95 to 100 wt% (e.g. 98 to 100 wt%) of the protein in the spray dried roe of the present invention is in its original configuration (i.e. in the same configuration as in the fresh roe).
- the spray dried roe of the present invention preferably comprises 10 wt% to 30 wt%, more preferably 10 wt% to 25 wt%, still more preferably 15 wt% to 25 wt% and yet more preferably 15 to 20 wt% of lipid, based on the total weight of the spray dried roe.
- Preferably all of the lipids present in the spray dried roe is derived from the roe per se, i.e. no external lipids are added.
- the lipids in the spray dried roe of the present invention are in their original configuration (i.e. they are in the same configuration as they were in in the fresh roe from which the spray dried roe is derived).
- the lipids are not oxidised relative to their configuration in the fresh roe.
- 80 to 100 wt%, more preferably 90 to 100 wt%, still more preferably 95 to 100 wt% (e.g. 98 to 100 wt%) of the lipid in the spray dried roe of the present invention is in its original configuration (i.e. in the same configuration as in the fresh roe).
- the lipid preferably comprises 10 wt% to 40 wt%, more preferably 15 wt% to 25 wt% and still more preferably 20 wt% to 30 wt% (e.g. 22 wt% to 26 wt%) of neutral lipids, based on the total weight of the lipid.
- the lipid preferably comprises 60 wt% to 90 wt%, more preferably 65 wt% to 85 wt%, still more preferably 70 wt% to 80 wt% (e.g. 74 wt% to 78 wt%) of polar lipids, based on the total weight of the lipid.
- the lipids preferably comprise 40 wt% to 75 wt%, more preferably 50 wt% to 70 wt%, and still more preferably 55 wt% to 65 wt% (e.g. 60 to 65 wt%) of phosphatidylcholine (PC), based on the total weight of the lipid.
- PC phosphatidylcholine
- a high proportion of polar lipids (e.g. phosphatidylcholine) compared to neutral lipids can be beneficial as polar lipids are water soluble while neutral lipids are not, and thus polar lipids can be easier to digest, particularly in those with impaired liver or gallbladder function, as solubilisation by bile salts is not required. This is one of the many advantages achieved by incorporating the ingredients of roe into a stable spray dried form.
- the spray dried roe of the present invention preferably contains a high level of omega-3 fatty acids relative to the level of omega-6 fatty acids. This is advantageous because modern diets typically contain a high ratio of omega-6 fatty acids to omega-3 fatty acids which can have negative health effects.
- the spray dried roe of the present invention preferably comprises omega-3 fatty acids and omega-6 fatty acids in a weight ratio of from 15:1 to 25:1 , preferably from 17:1 to 20:1.
- the spray dried roe of the present invention preferably comprises 2 wt% to 10 wt%, preferably 3 wt% to 5 wt% of omega-3 fatty acids, based on the total weight of the spray dried roe.
- the spray dried roe of the present invention preferably comprises 0.1 wt% to 0.5 wt%, preferably 0.15 wt% to 0.25 wt% of omega-6 fatty acids, based on the total weight of the spray dried roe.
- the spray dried roe of the present invention has a lipid profile substantially the same as, e.g. the same as, the lipid profile of the fresh roe from which the spray dried roe is derived.
- the spray dried roe of the present invention preferably comprises docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) in a weight ratio of from 1 :1 to 5:1 , preferably from 2:1 to 3:1 .
- DHA is important for neural and visual development and function. It is a structural lipid of the nervous system and a crucial component of brain, retina and other neural tissues. However, most sources of omega- 3 fatty acids are richer in EPA than DHA.
- the spray dried roe of the present invention preferably comprises 1 wt% to 5 wt%, preferably 2 wt% to 3 wt%, of docosahexaenoic acid (DHA), based on the total weight of said spray dried roe.
- the spray dried roe of the present invention preferably comprises 0.2 wt% to 5 wt%, preferably 0.75 wt% to 1.5 wt%, of eicosapentaenoic acid (EPA), based on the total weight of said spray dried roe.
- DHA docosahexaenoic acid
- EPA eicosapentaenoic acid
- Fish roe has a balanced amino acid profile, beneficially including a high level of leucine.
- the spray dried roe of the present invention preferably comprises 3 wt% to 12 wt%, preferably 5 wt% to10 wt%, more preferably 7 wt% to 9 wt% of leucine, based on the total weight of the spray dried roe.
- Leucine is an essential amino acid used in the biosynthesis of proteins and which is believed to be of importance for the stimulation of muscle protein synthesis.
- the spray dried roe of the present invention has an amino acid profile substantially the same as, e.g. the same as, the amino acid profile of the fresh roe from which the spray dried roe is derived.
- the spray dried roe consists essentially of ingredients derived from fresh roe.
- the spray dried roe of the present invention may comprise additional ingredients not derived from the fresh roe.
- the spray dried roe further comprises one or more ingredients selected from flavourings, preservatives, colourings, functional excipients, antioxidants and mixtures thereof. Description of process
- the present invention also provides a process for preparing spray-dried roe.
- the present invention provides a process for preparing spray-dried roe as hereinbefore defined, comprising:
- the process of the present invention comprises a step of pre-treating the roe.
- the pre-treating step minimises deterioration of the raw material due to enzymatic and oxidative processes, and prepares the material for a fast drying process, enabling the roe to be spray dried effectively.
- the pre-treating step disrupts the structure of the roe, specifically the outer coating present on the roe. Disrupting this outer coating is thought to enable the roe to be spray dried effectively.
- the pre-treating step disrupts the outer coating (e.g. the chorion and the vitelline membrane) present on the roe.
- the pre-treating step may be carried out under an air atmosphere. Alternatively the pre-treating step may be carried out under inert conditions, e.g. under a nitrogen atmosphere.
- the pre-treating step may comprise any treatment which facilitates the spray-drying process, e.g. any process which disrupts the outer coating of the roe.
- the pre-treating step may, for example, comprise (i) mechanical crushing of the roe; and/or (ii) treating the roe with steam.
- the pre-treating step comprises the steps of: (i) mechanical crushing of the roe and (ii) treating the roe with steam.
- the pre-treating step comprises treating the roe with steam (e.g. injecting the roe with steam).
- the roe is treated with steam at a temperature of 50 to 90 °C, more preferably at a temperature of 60 to 80 °C, and yet more preferably at a temperature of about 70 °C, e.g. the roe is treated with steam to a final temperature of 50 to 90 °C, more preferably to a final temperature of 60 to 80 °C, and yet more preferably to a final temperature of about 70 °C.
- the roe is preferably treated with steam for 30 minutes to 5 hours, more preferably for 1 to 4 hours, still more preferably for 1.5 to 3.5 hours and yet more preferably for 2 to 3 hours, e.g. for about 2.5 hours.
- steam treatment at these temperatures and/or for these durations disrupts the outer coating of the roe with minimal denaturing of the proteins and minimal oxidation of the lipids present in the roe.
- steam treatment inactivates enzymes that catalyse the formation of odour components such as trimethylamine.
- the use of steam treatment in the pre-treating step is cost efficient, reliable and scaleable, allowing the process of the invention to be carried out on a multi-ton scale (e.g. 100 ton scale) with minimal deterioration of the raw material.
- the roe is initially frozen.
- preferred processes of the invention comprise a further step of freezing said roe after it has been obtained.
- the roe is frozen at a temperature of -50 °C to -10 °C, preferably -30 °C to -10 °C.
- the roe is frozen after the step of obtaining the roe, and preferably prior to the pre-treating step.
- the roe is frozen prior to the pre treating step, and the pre-treating step preferably thaws the roe.
- the frozen roe is crushed, e.g. mechanically crushed, prior to pre-treating with steam.
- the steaming process may be controlled so that the enzymes which generate odour components are quickly deactivated, but no denaturation of the roe proteins or oxidative stress of the roe lipid occurs
- the roe is washed.
- the roe can be washed with salt water.
- the roe can be washed with pure water (i.e. non salt water).
- washing is carried out after immediately after the roe is separated from fish, i.e. after filleting.
- the roe is not washed or treated with a sodium hydroxide solution (e.g. an aqueous sodium hydroxide solution). This is because washing or treating with a sodium hydroxide solution can hydrolyse and/or destroy the roe, such that it loses its functional properties.
- One preferred process of the invention comprises:
- the roe is preferably unripe roe. Whilst ripe roe can be used as caviar, unripe roe is generally a low value residual. Advantageously the present invention allows unripe roe to be transformed into a high value end product.
- the spray drying process kills bacteria and fungi in the roe.
- the spray dried roe produced by the spray drying process may be used directly.
- a sterilisation step may be carried out after the spray drying step in order to provide a completely sterile product.
- the spray dried roe and the compositions of the present invention have a wide variety of potential applications and uses.
- the spray dried roe can be used per se, for example for direct oral administration or to be sprinkled over other foods.
- the spray dried roe and compositions of the present invention may be used in human nutrition and/or in animal nutrition.
- Specific uses of the spray dried roe and compositions of the present invention in human nutrition include in snacks (e.g. crisps), in cooking (e.g. as an ingredient in a recipe), in baking (e.g. in the production of bread or other baked goods and bakery products), as an additive to flour, in sports supplements, in medical food, in food or nutritional supplements for the elderly and in maternal and infant nutrition (e.g. as a supplement for pregnant or breast feeding women or an additive to infant formula feed or baby food).
- spray dried roe and compositions of the present invention in human nutrition are as an emergency food supplement or as a component in an emergency food supplement or emergency rations (e.g. for people following disasters), and as warfare rations or as a component in warfare rations (e.g. for military personnel). Further uses of the spray dried roe and compositions of the present invention in human nutrition are in brain nutrition and clinical nutrition.
- spray dried roe and compositions of the present invention in animal nutrition include in animal feed (e.g. livestock feed, pet food, fish food, aquaculture, chicken feed).
- animal feed e.g. livestock feed, pet food, fish food, aquaculture, chicken feed.
- the spray dried roe and compositions of the present invention may also be used in feed for poultry in order to enhance the omega-3 fatty acid content in poultry products and eggs.
- compositions of the present invention may be used as a starting point for subsequent processing and applications, e.g. extracts.
- the present invention also provides a package containing spray dried roe or a composition as hereinbefore defined.
- the package may take any form suitable to contain the spray dried roe or composition, e.g. a bag, a box, a sachet, a tub, a sack, a barrel, a jar, a bottle or a pouch.
- the package is air tight and/or opaque.
- the package is selected from aluminum bags (e.g.
- the package is an aluminum bag, more preferably a laminated aluminum bag.
- Advantageously packaging the spray dried roe in air tight and/or opaque packaging enables it to be stored for extended periods of time without deterioration of the product.
- Example 1 Production of spray-dried roe using pre-treatment with steam
- Fresh herring roe was frozen and stored at -20 °C. The frozen roe was then crushed mechanically using conventional crushing equipment. Steam was then injected into the crushed frozen roe up to a final roe temperature of 15 °C or 70 °C. To achieve a final temperature of 70 °C, steam was injected into 60 kg of crushed frozen roe for 2.5 h. The thawed, liquefied, roe was transferred to a receiving tank prior to spray drying. The thawed roe was then spray dried using conventional spray drying equipment. Composition of spray dried roe
- composition of the spray dried roe produced using steam pre-treatment at 70 °C is shown in Table 1 below.
- the composition was determined using conventional techniques.
- Table 2 The fatty acid composition of the lipid component is shown in Table 3:
- omega-3 fatty acids especially DHA and EPA
- phospholipid mainly choline
- spray-dried roe contains long and short chain proteins, including polypeptides, peptides and free amino acids.
- the protein fraction contains bioactive components which are kept intact ⁇
- the biological functions of all of the components are able to provide all elements necessary for the creation of a functional organism, including the brain, eyes, nerve system, immune system, digestion system.
- the amino acid composition of the spray dried product is outlined in Table 4. Such an amino acid composition is of importance for a number of applications of the spray dried product, in particular applications related to human nutrition, sports supplements, emergency food supplements, infant formula etc.
- the spray dried roe made according to Example 1 has an amino acid profile that is high in essential amino acids (see Table 5 below). This fact, together with a high amount of essential fatty acids (see Table 3 above), make the spray dried roe well- suited for particular applications related to human nutrition, sports supplements, emergency food supplements, infant formula etc.
- the formulations may further comprise additives, e.g. flavourings, colourings, sweeteners (e.g. sucralose), guar gum, citric acid etc.
- the bread was made by a conventional bread making procedure with the exception that the spray dried roe was additionally added along with the yeast.
- the nutritional data for the bread is shown in Table 7 below.
- Table 7 shows that the bread contains high levels of EPA and particularly of DHA.
- the bread contained the equivalent of 12 omega-3 capsules of krill oil.
- Example 4 Production of fish burgers containing spray dried roe
- the spray dried roe has been tested as an ingredient in the industrial production of fish-burgers.
- a test production was carried out making products that contained 3% of the spray dried roe.
- the ingredients used in the production of the fish burgers are shown in Table 8 below.
- the fish burgers were produced by a conventional procedure except that the spray dried roe was added at the same time as the salt and pepper.
- the nutritional data for the fish burgers is shown in Table 9 below versus conventional burgers lacking the spray dried roe supplement.
- the main ingredient in this product is the white fish haddock.
- White fish contains very little DHA.
- Table 9 shows that the fish burgers produced with 3 wt% spray dried roe contained 75 mg DHA/100 g product. The product had satisfactory storage stability. Fortification of white fish products with spray dried roe provides a significant nutritional improvement of the product.
- Imitation crab meat is a seafood product made by blending processed fish, known as surimi, with various texturizing ingredients, flavorings, and colorants.
- the fish used in the manufacture of imitation crab meat is most commonly white fish, such as pollock, that are low in omega-3 fatty acids.
- Surimi was produced using 4 wt% spray dried roe. Surimi base and water were mixed. The dry ingredients, plus the spray dried roe, and oil were added and the mixture was cut until 5 °C. Salt was added and the mixture was cut until 10 °C. The ingredients (other than the spray dried roe) are shown in Table 10 below.
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Marine Sciences & Fisheries (AREA)
- Nutrition Science (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Insects & Arthropods (AREA)
- Mycology (AREA)
- Wood Science & Technology (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
A composition comprising spray dried roe, wherein the spray dried roe is in the form of a powder and comprises less than 10 wt% water, based on the total weight of the spray dried roe.
Description
Composition comprising spray dried roe
INTRODUCTION
The present invention relates to compositions such as dietary supplements, nutritional supplements, food products and pharmaceutical compositions, comprising spray dried roe, wherein the spray dried roe is in the form of a powder and comprises less than 10 wt% water. The present invention also relates to the spray dried roe per se and to a process for preparing the spray dried roe. The invention further relates to a package (e.g. pouch, bottle, and canister) containing the composition or spray dried roe.
BACKGROUND
It is known that marine organisms are a potential source of compounds for human nutrition and health benefits. Three types of long chain omega-3 fatty acids come from marine sources: eicosapentaenoic acid (EPA), docosapentaenoic acid (DPA) and docosahexaenoic acid (DHA). These fatty acids help facilitate important immune functions, gene expression and platelet aggregation, and also help maintain membrane fluidity and structure, cell signalling pathways, and synthesis of physiologically important chemicals such as prostaglandins. Long chain omega-3 fatty acids are also known for their ability to reduce inflammation.
Polyunsaturated fatty acids (PUFAs) are essential for normal human growth. However, only minor quantities of the beneficial w-3 PUFAs eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) are synthesized by human metabolism. Rather PUFAs are obtained via dietary or nutritional supplementation and modified into other beneficial metabolites. A vast literature base is available on the health benefits and biological roles of w-3 PUFAs and their metabolism.
Today, various governments and health organizations recommend dietary intakes for total n-3 PUFA of 1 .4 to 2.5 g/d, with EPA plus DHA ranging from 140 to 600 mg/d. Unfortunately, in many western countries, these recommendations are not met by the majority of people. Therefore, other dietary sources of EPA and DHA are being sought. Food enrichment may be the best long-term solution to boost intake of long chain n-3 PUFA.
In light of recent consumer demand for food products containing healthier oils, manufacturers have introduced several foods fortified with omega-3 fatty acids. The
main categories of foods being fortified with omega- 3s are dairy products, nutritional beverages and baked goods. The chief sources of EPA and DHA are fish oils or purified preparations from microalgae, which when added to foods, impart a fishy flavour that is considered unacceptable.
Another concern of today's nutritionists is the high ratio of omega 6 to omega 3 fatty acids of modern human food (up to 50:1 compared with 1 :1 in ancient times). Many food manufacturers are in the process of reformulating their food products towards healthier compositions. Numerous studies have demonstrated that omega-3 fatty acids have positive effects on preventing or curing diseases like heart disease, cancer, rheumatoid arthritis, diabetes, ulcerative colitis, Raynaud's disease, allergies, eczema, skin thickening, weight gain and a host of other diseases.
SUMMARY OF INVENTION
Viewed from a first aspect, the present invention provides a composition comprising spray dried roe, wherein said spray dried roe is in the form of a powder and comprises less than 10 wt% water, based on the total weight of the spray dried roe.
Viewed from a further aspect the present invention provides spray dried roe in the form of a powder, wherein said spray dried roe comprises less than 10 wt% water, based on the total weight of the spray dried roe.
Viewed from a further aspect the present invention provides a process for preparing spray-dried roe as hereinbefore defined, comprising:
(i) obtaining roe;
(ii) pre-treating said roe; and
(iii) spray-drying said roe.
Viewed from a further aspect the present invention provides a package containing spray dried roe as hereinbefore defined.
DEFINITIONS
As used herein the term“spray drying” refers to a method of producing a dry powder from a liquid or slurry by rapidly drying with a gas. In a typical spray drying process, a liquid or slurry is dispersed by an atomiser or spray nozzle into droplets and hot gas is blown into the droplets to evaporate the liquid therefrom. Usually the process is carried out in an air atmosphere, but other gases such as nitrogen may alternatively be used. As would be readily understood by a skilled person, spray drying
does not include freeze drying (lyophilisation) or vacuum drying. As used herein the term“spray dried” refers to a product obtained from a spray drying process.
As used herein the term“roe” refers to the eggs of fish. The term encompasses both unripe and ripe eggs taken from the ovaries of fish. The outer surface of an egg consists of a coating that acts as a solid shield (the chorion and vitelline membrane) that protects the interior.
As used herein the term “powder” refers to an assembly of solid particles. Powders may be characterised by the size of the particles in the assembly. When the term“particle size” is used herein, the average diameter of particles is meant. Particle size may be determined, for example, by laser diffraction.
As used herein the term“fatty acid” refers to a carboxylic acid or a carboxylic acid moiety (i.e. the carboxylic acid without the acid hydrogen) with an aliphatic hydrocarbon chain which may be saturated or unsaturated. Typically the hydrocarbon chain comprises 6-22 carbon atoms.
As used herein the term“omega-3 fatty acid” refers to a polyunsaturated fatty acid (PUFA) that has the first double bond in the hydrocarbon chain, when viewed from the free end of the hydrocarbon chain (i.e. the end furthest from the carboxylic acid group), between the third and fourth carbon atoms from the free end of the hydrocarbon chain.
As used herein the term“omega-6 fatty acid” refers to a polyunsaturated fatty acid that has the first double bond in the hydrocarbon chain, when viewed from the free end of the hydrocarbon chain (i.e. the end furthest from the carboxylic acid group), between the sixth and seventh carbon atoms from the free end of the hydrocarbon chain.
As used herein the term“dietary supplement” refers to a product intended for ingestion, alongside a human or animal diet, that provides nutrients that the human or animal might otherwise not consume in sufficient quantities (e.g. through their regular diet). Typically a dietary supplement does not contain a significant amount of calories.
As used herein the term“nutritional supplement” refers to a product intended for ingestion by a human or animal that provides nutrients that the human or animal might otherwise not consume in sufficient quantities (e.g. through their regular diet) as well as a source of calories. Examples of nutritional supplements include meal replacements, nutritional drinks and energy bars.
As used herein the term“sports supplement” refers to a nutritional supplement specifically designed to provide nutrients to enhance or improve a person’s
performance during sport or exercise, their recovery following sport or exercise and/or the effects of sport or exercise on them.
As used herein the term“food product” refers to any substance that is intended to be consumed by a human or animal. The term encompasses products that are themselves food products as well as ingredients of such products, i.e. products, which after combination with other ingredients, are food products.
DESCRIPTION OF INVENTION
Description of composition
The present invention provides a composition comprising spray dried roe, wherein the spray dried roe is in the form of a powder and comprises less than 10 %wt water. Roe is an extremely attractive ingredient for use in, e.g. food and health products, in light of its ideal balance of ingredients and in particular its omega 6 to omega 3 fatty acid ratio. The problem with roe, however, is that it has low storage stability and has a strong fishy smell and flavour which is often undesirable. These problems are overcome by utilising spray dried roe.
The compositions of the invention comprising spray dried roe provide therapeutic and/or nutritional benefits to animals, including human and non-human animals. Representative examples of non-human animals include dogs, cats, chickens, turkeys, horses, sheep, cows, pigs, guinea pigs and fish. Domestic animals, e.g. pets, are one preferred group of non-human animals.
The therapeutic and/or nutritional benefit is achieved as a result of the composition of the spray dried roe. Examples of neurological conditions that may be improved, maintained or treated by the compositions of the invention include dementia, cognitive dysfunction, DHA or neurological deficiencies, overall brain health, mood, memory and concentration, brain and retina cell survival during both aging and the initiation and progression of neurodegenerative diseases, digestive and/or fat absorption issues. The compositions of the present invention can also improve, maintain or treat infertility, particularly male infertility.
Preferably the composition is a dietary supplement, a nutritional supplement, a food product or a pharmaceutical composition.
In one preferred embodiment of the present invention, the composition is a food product. The food product may be a human food or an animal food. Particularly
preferably the food is an animal food, e.g. pet food. The pet food may be dry feed or wet feed.
When the composition of the invention is a food product, the product may be any conventional food type. Representative examples include animal feed (e.g. pet food, aquaculture feed), infant formula feed, baby food, food for children and youngsters, drinks (e.g. milk, milk shake, soft drink, juice, smoothie etc.), baked goods (e.g. bread), meat or fish products (e.g. burgers, sausages, fish cakes, crab sticks, etc.), sports products, snack foods (e.g. chocolate bars), sauces, soups, toppings or dressings, dairy products (e.g. yoghurts, cheese), pregnancy nutrition food products and frozen meals. Generally the food products are identical in composition to conventional food products except for the addition of spray dried roe.
Preferred food products of the present invention comprise spray dried roe as herein defined in an amount of 0.5 wt% to 50 wt%, more preferably 1 wt% to 40 wt%, yet more preferably 1 wt% to 20 wt%, and still more preferably 1 wt% to 10 wt%, based on the total weight of the food product. Most preferably the food product of the present invention comprises spray dried roe as hereinbefore defined in an amount of 1 wt% to 5 wt%, based on the total weight of the food product.
When the composition of the invention is a dietary supplement, the supplement may be in any conventional form. Representative examples of suitable forms include pills, powders, drinks or bars. Generally the dietary supplement is in a form suitable for ingestion.
Preferred dietary supplements of the present invention comprise spray dried roe as herein defined in an amount of 1 wt% to 80 wt%, more preferably 5 wt% to 70 wt%, yet more preferably 10 wt% to 60 wt%, and still more preferably 15 wt% to 50 wt%, based on the total weight of the dietary supplement.
Preferred dietary supplements further comprise one or more nutraceutical agents. The person skilled in the art can readily identify suitable agents. Representative examples of suitable agents include thiamin, riboflavin, nicotinic add pantothenic acid, pyridoxine, biotin, folic acid, vitamin B12, lipoic acid, ascorbic acid, vitamin A, vitamin D, vitamin E, vitamin K, thiamine pyrophosphates (TPP), flavin mononucleotide (FMM), flavin adenine dinucleotide (FAD), Nicotinamide adenine dinucleotide, nicotinamide adenine dinucleotide phosphate (NADP), coenzyme A (CoA), coenzyme Q10 (CoQ10), pyridoxal phosphate, biocytin, tetrahydrofolic acid, coenzyme B 12, lipoyllysine, 1 1 -cis-retinal, 25-dihydroxycholecalciferol, carnitine, alfa carotene, beta carotene, gamma carotene, black currant, ginseng, ginko biloba and
cinnamon. These agents may also be present in other compositions of the invention, i.e. nutritional supplements and food products.
When the composition of the invention is a nutritional supplement, the supplement may be in any conventional form. Preferably the nutritional supplement of the present invention is in the form of food, e.g. a meal, a snack or a drink. Preferred nutritional supplements of the present invention further comprise carbohydrate, protein, fat and mixtures thereof. Conventional sources of carbohydrate, protein and fat may be used.
Preferred nutritional supplements of the present invention comprise spray dried roe as herein defined in an amount of 0.5 wt% to 50 wt%, more preferably 1 wt% to 40 wt%, yet more preferably 1 wt% to 20 wt%, and still more preferably 1 wt% to 10 wt%, based on the total weight of the nutritional supplement.
Preferred compositions, and particularly preferred dietary supplements, nutritional supplements and food products, further comprise one or more further substances. The preferred further substances depend on the type of the composition. Generally, however, the one or more further substances are selected from flavourings, sweeteners, minerals, binders, smell modifiers, fillers, surfactants, preservatives, colourings, antioxidants, sorbents and mixtures thereof. Antioxidants are a particularly preferred further substance.
Particularly preferred compositions comprise one or more antioxidants. Preferred antioxidants are selected from rosemary, vitamin E, astaxanthine, carnitine, ascorbyl palmitate, spermine, curcumin and mixtures thereof, more preferably curcumin and spermine and mixtures thereof and still more preferably circumin. Particularly preferred compositions comprise curcumin in an amount from 10 to 500 mg curcumin/100 g of the composition, more preferably in an amount from 50 to 250 mg curcumin/100 g of the composition and still more preferably in an amount from 100 to 200 mg curcumin/100 g of the composition. The addition of antioxidants (e.g. curcumin) advantageously enhances the stability (e.g. prevents oxidation) of the spray dried roe, enabling the composition to be stored for extended periods of time.
A significant advantage of the spray dried roe of the present invention is its oxidation and flavour stability. Without wishing to be bound by theory, this is thought to be due to the largely intact structure achieved by the spray drying process and the naturally high content of antioxidants, which are optionally supplemented.
Some preferred compositions of the present invention further comprise flavourings, and preferably comprise flavourings selected from volatile oils, synthetic
flavor oils, flavoring aromatics, oils, liquids, oleoresins and extracts derived from plants leaves, flowers, fruits, citric oils, lemon, orange, grape, lime and grape fruit, fruit essences including apple, pear, peach, banana, grape, berry, strawberry, raspberry, blueberry, blackberry, cherry, plum, pineapple, apricot, other fruit flavors such as aldehydes and esters, benzaldehyde (cherry almond), citral, alpha-central (lemon lime), neral, beta-citral (lemon lime), decanal (orange lemon), aldehyde C-8 (citrus fruits), aldehyde C-9 (citrus fruits), aldehyde C-12 (citrus fruits), tolyl aldehyde (cherry almond), 2,6-dimethyloctanal (green fruit), 2-dodedenal (citrus mandarin), chocolate, cocoa, almond, cashew, macadamia nut, coconut, mint, chili pepper, pepper, cinnamon, vanilla and tooty fruity, diacetyl acetylpropionyl, acetoin, isoamyl acetate, benzaldehyde, cinnamaldehyde, ethyl propionate, methyl anthranilate, limonene, ethyl decadienoate, allyl hexanoate, ethyl maltol, ethylvanillin, methyl salicylate, salt, sugar, glutamic acid salts, glycine salts, guanylic acid salts, inosinic acid salts, 5’- ribonucleotide salts, acetic acid, ascorbic acid, citric acid, fumaric acid, lactic acid, malic acid, phosphoric acid and tartaric acid.
Some preferred compositions of the present invention further comprise sweeteners. Preferred sweeteners are selected from glucose, invert sugar, fructose, saccharin and its various salts, cyclamic acid and its various salts, aspartame, dihydrochalcone, sugar alcohols including sorbitol syrup, luo han, cyclamate, saccharin, sucralose, mogorosides, brazzein, curculin, erythritol, fructooligosaccharide, glycyrrhizin, glycerol, hydrogenated starch hydrolysates, inulin, isomalt, isomaltooligosaccharide, isomaltulose, lactitol, mogroside mix, mabinlin, maltitol, maltodextrin, mannitol, miraculin, monatin, monellin, osladin, pentadin, polydextrose, psicose, sorbitol, stevia, tagatose, thaumatin, xylitol, acesulfame potassium, advantame, alitame, salt of aspartame-acesulfame, sodium cyclamate, dulcin, glucin, neohesperidin dihydrochalcone, neotame, P-4000 and saccharin.
Some preferred compositions of the present invention further comprise minerals. Preferred minerals are selected from calcium, iron, zinc, selenium, copper, iodine, magnesium, phosphorus and chromium
Some preferred compositions of the present invention further comprise preservatives. Preferred preservatives are selected from organic acid salts, vitamins, essential oils, sorbic acid, sorbates, sodium sorbate, benzoic acid, benzoates, sodium benzoate, benzoic acid, hydroxybenzoates, sulfur dioxide, sulphites, nitrites, nitrates, lactic acid, propionic acid, sodium propionate, ascorbic acid, sodium ascorbate, butylated hydroxytoluene, butylated hydroxyanisole, gallic acid, sodium gallate,
tocopherols, vitamin A, vitamin E, vitamin C, retinyl palmitate, selenium, amino acids including cysteine and methionine, citric acid, sodium citrates, acetic acid, hydrogen peroxide and nisin. Suitable preservative processes include fermentation, margination, and acidification.
Some preferred compositions of the present invention further comprise colourings. Preferred colourings are selected from natural colourings and artificial colourings such as E104 (Quinoline yellow), E122 (carrmoisine), E124 (ponceau 4R), E131 (Patent Blue V), E142 (Green S), FD&C Blue No. 1 , FD&C Blue No.2, FD&C Green No. 3, FD&C Red No.3, FD&C Red No. 40, FD&C Yellow No.5, FD&C Yellow No.6, beet juice, beet powder, Beta-Apo-8'-carotenal, Beta carotene, Canthaxanthin, caramel, carmine, carrot oil, cochineal extract, cottonseed flour, ferrous gluconate, ferrous lactate, fruit juice, grape colour extract, lycopene, tomato extract, paprika, paprika oleoresin, riboflavin, saffron, spirulina extract, tumeric, tumeric oleoresin, vegetable juice.
Some preferred compositions of the present invention comprise binders. Preferred binders are selected from potato starch, flour, eggs and tapioca flour.
Some preferred compositions of the present invention comprise sorbents. Particularly suitable sorbents include free-radical scavengers and oxygen scavengers.
Some preferred compositions of the present invention comprise smell modifiers. Any suitable conventional smell modifiers may be used.
Some preferred compositions of the present invention comprise surfactants. Any suitable conventional surfactants may be used.
Some preferred compositions of the present invention comprise fillers. Any suitable conventional fillers may be used.
Description of roe
The present invention provides spray dried roe in the form of a powder. Preferably the powder is dry powder. Preferably the powder is a dehydrated powder. Preferably the powder is free flowing and can therefore be handled and manipulated without the particles comprising the powder sticking together.
The spray dried roe of the present invention advantageously contains all the desirable nutritional components of fresh roe in a form with an attractive texture and flavour profile and good stability (e.g. to oxidation). Roe has an ideally balanced and highly attractive nutritional profile with high amounts of phospholipids, predominantly phosphatidylcholine, with a very high percentage of omega-3 long chain
polyunsaturated fatty acids, potent lipophilic antioxidants with carotenoid structures (e.g. astaxanthin, canthaxanthin) and a large portion of protein with an attractive amino acid profile. The spray dried roe of the present invention is highly advantageous in that it comprises the same ideal balance of ingredients as fresh roe but may be stably stored for longer periods of time. Advantageously the spray drying process employed in the present invention does not cause oxidation, e.g. of the lipids, does not induce the generation of smelly amines, and does not destroy the overall composition of the fresh roe.
The spray dried roe of the present invention comprises less than 10 wt% water, based on the total weight of the spray dried roe. Preferably the spray dried roe comprises less than 8 wt% water, more preferably less than 7 wt% water and still more preferably less than 6 wt% water, based on the total weight of the spray dried roe. Most preferably the spray dried roe comprises less than 5 wt% water, based on the total weight of the spray dried roe. The minimum amount of water may be, for example, 0.5 or 0.1 wt%, based on the total weight of the spray dried roe.
Advantageously the spray dried roe of the invention comprises all the components of fresh roe minus the majority, e.g. all, of the water. Thus the spray dried roe provides the nutrients of fresh roe but in a form which is stable, lightweight, easy to store and transport, and suitable for use in many compositions and applications. Preferably the spray dried roe of the present invention comprises at least 90 wt% ingredients derived from fresh roe, based on the total weight of the spray dried roe. More preferably the spray dried roe of the present invention comprises at least 92 wt%, still more preferably at least 93 wt% and yet more preferably at least 94 wt% ingredients derived from fresh roe, based on the total weight of the spray dried roe. Most preferably the spray dried roe of the present invention comprises at least 95 wt% ingredients derived from fresh roe, based on the total weight of the spray dried roe. The maximum amount of ingredients derived from fresh roe may be 100 wt%, based on the total weight of the spray dried roe. In a preferred spray dried roe of the present invention the spray dried roe consists essentially of, e.g. consists of, ingredients derived from fresh roe. Preferably the composition of the spray dried roe of the present invention is substantially the same as, e.g. is the same as, the composition of the fresh roe from which the spray dried roe is derived, except for the water content.
The spray dried roe of the present invention is preferably non-encapsulated. Encapsulation is often used when formulating fish oils to improve their solubility and/or bioavailability. Encapsulation (e.g. microencapsulation) materials, however, generally
have no nutritional value and can make up a significant weight proportion of an encapsulated product. Additionally, encapsulation (e.g. microencapsulation) of marine extracts that contain a high level of phospholipids can lead to an undesirable rubberlike appearance and/or texture. Advantageously the spray dried roe of the present invention provides a free flowing powder and does not require encapsulation.
The spray dried roe of the present invention is in the form of a powder, preferably a free flowing powder. Preferably the spray dried roe has a particle size (e.g. an average diameter) of less than 400 pm, more preferably less than 300 pm, and still more preferably less than 250 pm (e.g. less than 200 pm). Preferably the spray dried roe has a particle size (e.g. an average diameter) of greater than 20 pm, more preferably greater than 40 pm, and still more preferably greater than 50 pm (e.g. greater than 75 pm). Preferably the spray dried roe of the present invention has a particle size (e.g. an average diameter) of 20 to 400 pm, more preferably 40 to 250 pm, and still more preferably 50 pm to 200 pm. Yet more preferably the spray dried roe has a particle size (e.g. an average diameter) of 75 pm to 125 pm, more preferably about 100 pm. Alternatively the spray dried roe may have a preferred particle size of 1 to 50 pm, more preferably 5 to 25 pm and still more preferably about 10 pm.
The spray dried roe of the present invention may be derived from various marine species, e.g. fish or shellfish. The spray dried roe may be derived from saltwater or freshwater species. Preferably in the spray dried roe of the present invention the roe is selected from capelin roe, cod roe, herring roe, saithe roe, shrimp roe or salmon roe, preferably capelin roe, cod roe, herring roe or salmon roe, more preferably herring roe. Herring roe is particularly preferred as it provides an ideal balance of nutritional properties.
The spray dried roe of the present invention may be derived from unripe roe or ripe roe.
The spray dried roe of the present invention preferably comprises a large proportion of protein. Preferably the spray dried roe comprises 60 wt% to 90 wt%, more preferably 65 wt% to 85 wt% and still more preferably 70 to 80 wt% of protein based on the total weight of the spray dried roe. Alternatively the spray dried roe preferably comprises 60 wt% to 80 wt%, more preferably 65 wt% to 75 wt% of protein based on the total weight of the spray dried roe. Preferably all of the protein present in the spray dried roe is derived from the roe per se, i.e. no external protein is added.
Preferably the proteins, peptides and polypeptides (e.g. proteins) in the spray dried roe of the present invention are in their original configuration (i.e. they are in the
same configuration as they were in in the fresh roe from which the spray dried roe is derived). Preferably the proteins are not denatured or degraded, e.g. by hydrolytic processes, relative to their configuration in the fresh roe. Preferably 80 to 100 wt%, more preferably 90 to 100 wt%, still more preferably 95 to 100 wt% (e.g. 98 to 100 wt%) of the protein in the spray dried roe of the present invention is in its original configuration (i.e. in the same configuration as in the fresh roe).
The spray dried roe of the present invention preferably comprises 10 wt% to 30 wt%, more preferably 10 wt% to 25 wt%, still more preferably 15 wt% to 25 wt% and yet more preferably 15 to 20 wt% of lipid, based on the total weight of the spray dried roe. Preferably all of the lipids present in the spray dried roe is derived from the roe per se, i.e. no external lipids are added.
Preferably the lipids in the spray dried roe of the present invention are in their original configuration (i.e. they are in the same configuration as they were in in the fresh roe from which the spray dried roe is derived). Preferably the lipids are not oxidised relative to their configuration in the fresh roe. Preferably 80 to 100 wt%, more preferably 90 to 100 wt%, still more preferably 95 to 100 wt% (e.g. 98 to 100 wt%) of the lipid in the spray dried roe of the present invention is in its original configuration (i.e. in the same configuration as in the fresh roe).
In the spray dried roe of the present invention the lipid preferably comprises 10 wt% to 40 wt%, more preferably 15 wt% to 25 wt% and still more preferably 20 wt% to 30 wt% (e.g. 22 wt% to 26 wt%) of neutral lipids, based on the total weight of the lipid. In the spray dried roe of the present invention the lipid preferably comprises 60 wt% to 90 wt%, more preferably 65 wt% to 85 wt%, still more preferably 70 wt% to 80 wt% (e.g. 74 wt% to 78 wt%) of polar lipids, based on the total weight of the lipid. The lipids preferably comprise 40 wt% to 75 wt%, more preferably 50 wt% to 70 wt%, and still more preferably 55 wt% to 65 wt% (e.g. 60 to 65 wt%) of phosphatidylcholine (PC), based on the total weight of the lipid. A high proportion of polar lipids (e.g. phosphatidylcholine) compared to neutral lipids can be beneficial as polar lipids are water soluble while neutral lipids are not, and thus polar lipids can be easier to digest, particularly in those with impaired liver or gallbladder function, as solubilisation by bile salts is not required. This is one of the many advantages achieved by incorporating the ingredients of roe into a stable spray dried form.
The spray dried roe of the present invention preferably contains a high level of omega-3 fatty acids relative to the level of omega-6 fatty acids. This is advantageous because modern diets typically contain a high ratio of omega-6 fatty acids to omega-3
fatty acids which can have negative health effects. The spray dried roe of the present invention preferably comprises omega-3 fatty acids and omega-6 fatty acids in a weight ratio of from 15:1 to 25:1 , preferably from 17:1 to 20:1. The spray dried roe of the present invention preferably comprises 2 wt% to 10 wt%, preferably 3 wt% to 5 wt% of omega-3 fatty acids, based on the total weight of the spray dried roe. The spray dried roe of the present invention preferably comprises 0.1 wt% to 0.5 wt%, preferably 0.15 wt% to 0.25 wt% of omega-6 fatty acids, based on the total weight of the spray dried roe. Preferably the spray dried roe of the present invention has a lipid profile substantially the same as, e.g. the same as, the lipid profile of the fresh roe from which the spray dried roe is derived.
The spray dried roe of the present invention preferably comprises docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) in a weight ratio of from 1 :1 to 5:1 , preferably from 2:1 to 3:1 . DHA is important for neural and visual development and function. It is a structural lipid of the nervous system and a crucial component of brain, retina and other neural tissues. However, most sources of omega- 3 fatty acids are richer in EPA than DHA. The spray dried roe of the present invention preferably comprises 1 wt% to 5 wt%, preferably 2 wt% to 3 wt%, of docosahexaenoic acid (DHA), based on the total weight of said spray dried roe. The spray dried roe of the present invention preferably comprises 0.2 wt% to 5 wt%, preferably 0.75 wt% to 1.5 wt%, of eicosapentaenoic acid (EPA), based on the total weight of said spray dried roe.
Fish roe has a balanced amino acid profile, beneficially including a high level of leucine. The spray dried roe of the present invention preferably comprises 3 wt% to 12 wt%, preferably 5 wt% to10 wt%, more preferably 7 wt% to 9 wt% of leucine, based on the total weight of the spray dried roe. Leucine is an essential amino acid used in the biosynthesis of proteins and which is believed to be of importance for the stimulation of muscle protein synthesis. Preferably the spray dried roe of the present invention has an amino acid profile substantially the same as, e.g. the same as, the amino acid profile of the fresh roe from which the spray dried roe is derived.
In some preferred spray dried roes of the present invention the spray dried roe consists essentially of ingredients derived from fresh roe. Alternatively the spray dried roe of the present invention may comprise additional ingredients not derived from the fresh roe. Thus in some preferred spray dried roes of the present invention the spray dried roe further comprises one or more ingredients selected from flavourings, preservatives, colourings, functional excipients, antioxidants and mixtures thereof.
Description of process
The present invention also provides a process for preparing spray-dried roe. Thus the present invention provides a process for preparing spray-dried roe as hereinbefore defined, comprising:
(i) obtaining roe;
(ii) pre-treating the roe; and
(iii) spray-drying the roe.
The process of the present invention comprises a step of pre-treating the roe. Advantageously the pre-treating step minimises deterioration of the raw material due to enzymatic and oxidative processes, and prepares the material for a fast drying process, enabling the roe to be spray dried effectively. Without wishing to be bound by theory it is believed that the pre-treating step disrupts the structure of the roe, specifically the outer coating present on the roe. Disrupting this outer coating is thought to enable the roe to be spray dried effectively. Thus in a preferred process of the present invention the pre-treating step disrupts the outer coating (e.g. the chorion and the vitelline membrane) present on the roe. The pre-treating step may be carried out under an air atmosphere. Alternatively the pre-treating step may be carried out under inert conditions, e.g. under a nitrogen atmosphere.
In the process of the present invention the pre-treating step may comprise any treatment which facilitates the spray-drying process, e.g. any process which disrupts the outer coating of the roe. The pre-treating step may, for example, comprise (i) mechanical crushing of the roe; and/or (ii) treating the roe with steam. However, in preferred processes of the present invention the pre-treating step comprises the steps of: (i) mechanical crushing of the roe and (ii) treating the roe with steam.
In a particularly preferred process of the present invention the pre-treating step comprises treating the roe with steam (e.g. injecting the roe with steam). Preferably, the roe is treated with steam at a temperature of 50 to 90 °C, more preferably at a temperature of 60 to 80 °C, and yet more preferably at a temperature of about 70 °C, e.g. the roe is treated with steam to a final temperature of 50 to 90 °C, more preferably to a final temperature of 60 to 80 °C, and yet more preferably to a final temperature of about 70 °C. In processes of the present invention wherein the pre-treating step comprises treating the roe with steam, the roe is preferably treated with steam for 30 minutes to 5 hours, more preferably for 1 to 4 hours, still more preferably for 1.5 to 3.5 hours and yet more preferably for 2 to 3 hours, e.g. for about 2.5 hours.
Advantageously steam treatment at these temperatures and/or for these durations disrupts the outer coating of the roe with minimal denaturing of the proteins and minimal oxidation of the lipids present in the roe. Moreover it has been found that steam treatment inactivates enzymes that catalyse the formation of odour components such as trimethylamine. The use of steam treatment in the pre-treating step is cost efficient, reliable and scaleable, allowing the process of the invention to be carried out on a multi-ton scale (e.g. 100 ton scale) with minimal deterioration of the raw material.
In preferred processes of the invention, and particularly those employing a pre treating step comprising treating the roe with steam, the roe is initially frozen. Thus preferred processes of the invention comprise a further step of freezing said roe after it has been obtained. Preferred the roe is frozen at a temperature of -50 °C to -10 °C, preferably -30 °C to -10 °C. Preferably the roe is frozen after the step of obtaining the roe, and preferably prior to the pre-treating step.
In preferred processes of the present invention the roe is frozen prior to the pre treating step, and the pre-treating step preferably thaws the roe. Optionally the frozen roe is crushed, e.g. mechanically crushed, prior to pre-treating with steam. After the roe is thawed by steam, it may be subjected to further pre-treating steps or it may be spray dried without further pre-treatment. Advantageously the steaming process may be controlled so that the enzymes which generate odour components are quickly deactivated, but no denaturation of the roe proteins or oxidative stress of the roe lipid occurs
In some processes of the present invention the roe is washed. The roe can be washed with salt water. Alternatively the roe can be washed with pure water (i.e. non salt water). Preferably washing is carried out after immediately after the roe is separated from fish, i.e. after filleting. Preferably, the roe is not washed or treated with a sodium hydroxide solution (e.g. an aqueous sodium hydroxide solution). This is because washing or treating with a sodium hydroxide solution can hydrolyse and/or destroy the roe, such that it loses its functional properties.
One preferred process of the invention comprises:
(i) obtaining roe;
(ii) optionally washing said roe;
(iii) freezing said roe to produce frozen roe;
(iv) pre-treating said frozen roe with steam, preferably to thaw said frozen roe and disrupt the outer coating of the roe; and
(v) spray-drying the resulting roe.
Another preferred process of the invention comprises:
(i) obtaining roe;
(ii) optionally washing said roe;
(iii) freezing said roe to produce frozen roe;
(iv) crushing said frozen roe to produce crushed frozen roe;
(v) pre-treating said crushed frozen roe with steam (e.g. to a final roe temperature of 50 to 90 qC), preferably to thaw said frozen roe and disrupt the outer coating of the roe; and
(vi) spray-drying the resulting roe.
In the process of the present invention the roe is preferably unripe roe. Whilst ripe roe can be used as caviar, unripe roe is generally a low value residual. Advantageously the present invention allows unripe roe to be transformed into a high value end product.
Advantageously the spray drying process kills bacteria and fungi in the roe. Thus the spray dried roe produced by the spray drying process may be used directly. However, optionally a sterilisation step may be carried out after the spray drying step in order to provide a completely sterile product.
Description of uses
The spray dried roe and the compositions of the present invention have a wide variety of potential applications and uses. The spray dried roe can be used per se, for example for direct oral administration or to be sprinkled over other foods.
The spray dried roe and compositions of the present invention may be used in human nutrition and/or in animal nutrition. Specific uses of the spray dried roe and compositions of the present invention in human nutrition include in snacks (e.g. crisps), in cooking (e.g. as an ingredient in a recipe), in baking (e.g. in the production of bread or other baked goods and bakery products), as an additive to flour, in sports supplements, in medical food, in food or nutritional supplements for the elderly and in maternal and infant nutrition (e.g. as a supplement for pregnant or breast feeding women or an additive to infant formula feed or baby food). Further uses of the spray dried roe and compositions of the present invention in human nutrition are as an emergency food supplement or as a component in an emergency food supplement or emergency rations (e.g. for people following disasters), and as warfare rations or as a component in warfare rations (e.g. for military personnel). Further uses of the spray
dried roe and compositions of the present invention in human nutrition are in brain nutrition and clinical nutrition.
Specific uses of the spray dried roe and compositions of the present invention in animal nutrition include in animal feed (e.g. livestock feed, pet food, fish food, aquaculture, chicken feed). The spray dried roe and compositions of the present invention may also be used in feed for poultry in order to enhance the omega-3 fatty acid content in poultry products and eggs.
The spray-dried roe and compositions of the present invention may be used as a starting point for subsequent processing and applications, e.g. extracts.
Description of packaged product
The present invention also provides a package containing spray dried roe or a composition as hereinbefore defined. The package may take any form suitable to contain the spray dried roe or composition, e.g. a bag, a box, a sachet, a tub, a sack, a barrel, a jar, a bottle or a pouch. Preferably the package is air tight and/or opaque. Preferably the package is selected from aluminum bags (e.g. air-tight aluminum bags), polythene bags, polypropylene bags, foil aluminum pouches, BOPP metalized bags, matte bags, vacuum retort bags, flat bottom bags, freezer and/or sandwich bags, zip bags, grip seal bags, food storage bags, mircoperforation wicketed bread bags, biodegradable bags, compostable corn starch sacks, and barrels. Preferably the package is an aluminum bag, more preferably a laminated aluminum bag. Advantageously packaging the spray dried roe in air tight and/or opaque packaging (e.g. in a laminated aluminum bag) enables it to be stored for extended periods of time without deterioration of the product.
EXAMPLES
Materials
Herring roe was obtained from Norwegian producers of herring fillets
Example 1 : Production of spray-dried roe using pre-treatment with steam
Fresh herring roe was frozen and stored at -20 °C. The frozen roe was then crushed mechanically using conventional crushing equipment. Steam was then injected into the crushed frozen roe up to a final roe temperature of 15 °C or 70 °C. To achieve a final
temperature of 70 °C, steam was injected into 60 kg of crushed frozen roe for 2.5 h. The thawed, liquefied, roe was transferred to a receiving tank prior to spray drying. The thawed roe was then spray dried using conventional spray drying equipment. Composition of spray dried roe
The composition of the spray dried roe produced using steam pre-treatment at 70 °C is shown in Table 1 below. The composition was determined using conventional techniques.
Table 1
The breakdown of the neutral and polar lipids is shown in Table 2.
Table 2
The fatty acid composition of the lipid component is shown in Table 3:
Table 3
The spray dried product has the following key characteristics:
• A high level of omega-3 fatty acids, especially DHA and EPA, bound to phospholipid (mainly choline). Additionally the spray-dried roe contains long and short chain proteins, including polypeptides, peptides and free amino acids.
• The protein fraction contains bioactive components which are kept intact · The biological functions of all of the components are able to provide all elements necessary for the creation of a functional organism, including the brain, eyes, nerve system, immune system, digestion system.
The amino acid composition of the spray dried product is outlined in Table 4. Such an amino acid composition is of importance for a number of applications of the spray dried product, in particular applications related to human nutrition, sports supplements, emergency food supplements, infant formula etc.
Example 2: Nutritional supplements
The spray dried roe made according to Example 1 has an amino acid profile that is high in essential amino acids (see Table 5 below). This fact, together with a high amount of essential fatty acids (see Table 3 above), make the spray dried roe well-
suited for particular applications related to human nutrition, sports supplements, emergency food supplements, infant formula etc. Depending on the requirements of the application in question, the formulations may further comprise additives, e.g. flavourings, colourings, sweeteners (e.g. sucralose), guar gum, citric acid etc.
A normal adult requires 0.75 g of protein per kilogram of body weight per day. For strength and endurance athletes, protein requirements increase to around 1.2-1.7 g of protein per kilogram of body weight per day. Table 5 below compares the essential amino acid profile of a conventional nutritional supplement (whey protein) with the spray dried roe made according to Example 1 . It can be seen that each of the essential amino acids are present in the spray dried roe in the same or greater amounts than in whey protein.
Table 5
Example 3: Production of bread containing spray dried roe
Bread was made containing 1.45 wt % spray dried roe. The ingredients used in the production of the bread are shown in Table 6 below.
Table 6
The bread was made by a conventional bread making procedure with the exception that the spray dried roe was additionally added along with the yeast.
The nutritional data for the bread is shown in Table 7 below.
Table 7
Table 7 shows that the bread contains high levels of EPA and particularly of DHA. The bread contained the equivalent of 12 omega-3 capsules of krill oil.
Example 4: Production of fish burgers containing spray dried roe
The spray dried roe has been tested as an ingredient in the industrial production of fish-burgers. A test production was carried out making products that contained 3% of the spray dried roe. The ingredients used in the production of the fish burgers are shown in Table 8 below.
Table 8
The fish burgers were produced by a conventional procedure except that the spray dried roe was added at the same time as the salt and pepper.
The nutritional data for the fish burgers is shown in Table 9 below versus conventional burgers lacking the spray dried roe supplement.
Table 9
The main ingredient in this product is the white fish haddock. White fish contains very little DHA. Table 9 shows that the fish burgers produced with 3 wt% spray dried roe contained 75 mg DHA/100 g product. The product had satisfactory storage stability. Fortification of white fish products with spray dried roe provides a significant nutritional improvement of the product.
Example 5: Production of surimi and crabsticks containing spray dried roe
Imitation crab meat is a seafood product made by blending processed fish, known as surimi, with various texturizing ingredients, flavorings, and colorants. The fish used in the manufacture of imitation crab meat is most commonly white fish, such as pollock, that are low in omega-3 fatty acids. Surimi was produced using 4 wt% spray dried roe. Surimi base and water were mixed. The dry ingredients, plus the spray dried roe, and oil were added and the mixture was cut until 5 °C. Salt was added and the mixture was cut until 10 °C. The ingredients (other than the spray dried roe) are shown in Table 10 below.
Table 10
In order to produce crabsticks the resulting thick surimi paste was transformed into sheets about 25 cm wide and 1.2 mm thick, and then cooked. The thin strand was then bundled and rolled into a rope which was coloured, wrapped and cut to the desired size.
Claims
1. A composition comprising spray dried roe, wherein said spray dried roe is in the form of a powder and comprises less than 10 wt% water, based on the total weight of the spray dried roe.
2. A composition as claimed in claim 1 , wherein said composition is a dietary supplement, a nutritional supplement, a food product or a pharmaceutical composition.
3. A composition as claimed in claim 2, wherein said composition is a food product, and preferably an animal food product.
4. A composition as claimed in any one of claims 1 to 3, further comprising one or more antioxidants.
5. A composition as claimed in claim 4, wherein said antioxidants are selected from curcumin, spermine and mixtures thereof.
6. Spray dried roe in the form of a powder, wherein said spray dried roe comprises less than 10 wt% water, based on the total weight of the spray dried roe
7. Spray dried roe as claimed in claim 6, wherein said spray dried roe comprises at least 90 wt% ingredients derived from fresh roe.
8. Spray dried roe as claimed in claim 6 or 7, wherein said roe is selected from capelin roe, cod roe, herring roe, saithe roe, shrimp roe or salmon roe, preferably capelin roe, cod roe, herring roe or salmon roe, more preferably herring roe.
9. Spray dried roe as claimed in any one of claims 6 to 8, which comprises 60 wt% to 80 wt%, preferably 65 wt% to 75 wt% of protein based on the total weight of the spray dried roe.
10. Spray dried roe as claimed in any one of claims 6 to 9, which comprises 10 wt% to 30 wt%, preferably 15 wt% to 25 wt% of lipid, based on the total weight of the spray dried roe.
1 1 . Spray dried roe as claimed in any one of claims 6 to 10, which comprises omega-3 fatty acids and omega-6 fatty acids in a weight ratio of from 15:1 to 25:1 , preferably from 17:1 to 20:1.
12. Spray dried roe as claimed in any one of claims 6 to 1 1 , which comprises 2 wt% to 10 wt%, preferably 3 wt% to 5 wt% of omega-3 fatty acids, based on the total weight of the spray dried roe.
13. Spray dried roe as claimed in any one of claims 6 to 12, which comprises docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) in a weight ratio of from 1 :1 to 5:1 , preferably from 2:1 to 3:1 .
14. Spray dried roe as claimed in any one of claims 6 to 13, which comprises 1 wt% to 5 wt%, preferably 2 wt% to 3 wt%, of docosahexaenoic acid (DHA), based on the total weight of said spray dried roe.
15. Spray dried roe as claimed in any one of claims 6 to 14, which comprises 5 wt% to 10 wt%, preferably 7 wt% to 9 wt% of leucine, based on the total weight of the spray dried roe.
16. A process for preparing spray-dried roe as claimed in any one of claims 6 to 15, comprising:
(i) obtaining roe;
(ii) pre-treating said roe; and
(iii) spray-drying said roe.
17. A process as claimed in claim 16, wherein said pre-treating step comprises treating said roe with steam.
18. A package containing a composition as claimed in any one of claims 1 to 5 or spray dried roe as claimed in any one of claims 6 to 15.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB1801919.0A GB2570727A (en) | 2018-02-06 | 2018-02-06 | Composition comprising spray dried roe |
GB1801919.0 | 2018-02-06 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2019154879A1 true WO2019154879A1 (en) | 2019-08-15 |
Family
ID=61730964
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2019/052943 WO2019154879A1 (en) | 2018-02-06 | 2019-02-06 | Composition comprising spray dried roe |
Country Status (2)
Country | Link |
---|---|
GB (1) | GB2570727A (en) |
WO (1) | WO2019154879A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114209033A (en) * | 2021-11-04 | 2022-03-22 | 厦门东海洋食品有限公司 | Flying fish roe processing technology |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0681583B2 (en) * | 1988-06-03 | 1994-10-19 | 理研ビタミン株式会社 | Initial compound feed for crustacean culture |
CN1147350A (en) * | 1995-10-10 | 1997-04-16 | 姜洪涛 | Prodn of nutritive roe powder |
JP2003180290A (en) * | 2001-12-21 | 2003-07-02 | Fuji Bio Kenkyusho:Kk | Food seasoning and processed food each with flavor of seasoned cod roe |
US20100068371A1 (en) * | 2008-09-16 | 2010-03-18 | Dean Serena J | Stable, tasty, and attractive gourmet culinary item based upon air-dried and genuine caviar and method of making |
-
2018
- 2018-02-06 GB GB1801919.0A patent/GB2570727A/en not_active Withdrawn
-
2019
- 2019-02-06 WO PCT/EP2019/052943 patent/WO2019154879A1/en active Application Filing
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0681583B2 (en) * | 1988-06-03 | 1994-10-19 | 理研ビタミン株式会社 | Initial compound feed for crustacean culture |
CN1147350A (en) * | 1995-10-10 | 1997-04-16 | 姜洪涛 | Prodn of nutritive roe powder |
JP2003180290A (en) * | 2001-12-21 | 2003-07-02 | Fuji Bio Kenkyusho:Kk | Food seasoning and processed food each with flavor of seasoned cod roe |
US20100068371A1 (en) * | 2008-09-16 | 2010-03-18 | Dean Serena J | Stable, tasty, and attractive gourmet culinary item based upon air-dried and genuine caviar and method of making |
Non-Patent Citations (6)
Title |
---|
ALEX STRANIG: "Dry Ei: Getrockneter Forellen-Kaviar im Glas - Produkt der Woche - derStandard.at > Lifestyle", 3 November 2015 (2015-11-03), pages 1 - 1, XP055589019, Retrieved from the Internet <URL:https://derstandard.at/2000024620571/Dry-Ei-Getrockneter-Forellen-Kaviar-im-Glas> [retrieved on 20190515] * |
DATABASE GNPD [online] MINTEL; 20 March 2012 (2012-03-20), ANONYMOUS: "Spicy Cod Roe Corn Balls", XP055588841, retrieved from www.gnpd.com Database accession no. 1756307 * |
DATABASE GNPD [online] MINTEL; 28 April 2014 (2014-04-28), ANONYMOUS: "Spaghetti with Prawn & Dried Mullet Roe in Anchovy Sauce", XP055588994, retrieved from www.gnpd.com Database accession no. 2405261 * |
PETER KRACKOWIZER: "Fisch-Visionär - Kaviar-Pulvermacher Walter Grüll und seine beiden Weltneuheiten", PETERS REISE-MOSAIK-BLOG, 8 February 2015 (2015-02-08), pages 1 - 5, XP055589014, Retrieved from the Internet <URL:https://mosaikreisen.wordpress.com/2015/02/08/fisch-visionar-kaviar-pulvermacher-walter-grull-und-seine-beiden-weltneuheiten/> [retrieved on 20190515] * |
SATHIVEL S ET AL: "Physical and nutritional properties of catfish roe spray dried protein powder and its application in an emulsion system", JOURNAL OF FOOD ENGINEERING, BARKING, ESSEX, GB, vol. 95, no. 1, 1 November 2009 (2009-11-01), pages 76 - 81, XP026234386, ISSN: 0260-8774, [retrieved on 20090424], DOI: 10.1016/J.JFOODENG.2009.04.011 * |
SHAVIKLO AMIR REZA ED - SINGH NARPINDER: "Development of fish protein powder as an ingredient for food applications: a review", JOURNAL OF FOOD SCIENCE AND TECHNOLOGY, SPRINGER (INDIA) PRIVATE LTD, INDIA, vol. 52, no. 2, 13 June 2013 (2013-06-13), pages 648 - 661, XP035448436, ISSN: 0022-1155, [retrieved on 20130613], DOI: 10.1007/S13197-013-1042-7 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114209033A (en) * | 2021-11-04 | 2022-03-22 | 厦门东海洋食品有限公司 | Flying fish roe processing technology |
CN114209033B (en) * | 2021-11-04 | 2024-01-12 | 厦门东海洋食品有限公司 | Flying fish roe processing technology |
Also Published As
Publication number | Publication date |
---|---|
GB201801919D0 (en) | 2018-03-21 |
GB2570727A (en) | 2019-08-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA3036516A1 (en) | Ketogenic nutritional compositions | |
KR20080055788A (en) | Food with transfer devices and methods for manufacturing the same | |
CN101394756A (en) | Food and beverage products with improved taste impressions | |
EP2825065A1 (en) | Nutritional compositions including rrr -alpha tocopherol and polyunsaturated fatty acids | |
FR2721481A1 (en) | Novel dietary compositions based on phospholipids and their use as a nutritional supplement. | |
EP3599898B1 (en) | Liquid nutritional compositions containing oxidizable fish oil, rosmarinic acid and ferric iron | |
NO333013B1 (en) | Composition comprising bioactive amino acids or derivatives thereof and marine oil in a stable oil-in-water emulsion, and process for preparing said composition. | |
JP2001002569A (en) | Composition for improving memory | |
RU2505075C1 (en) | Nutritional compositions including fruit flakes containing docosahexaenoic acid | |
JPH09194362A (en) | Composition consisting of phospholipid containing docosahexanenoic acid and eicosapentanenoic acid | |
CN105828816A (en) | Uses of nutritional compositions including natural vitamin E, and polyunsaturated fatty acid | |
EP2983516A1 (en) | A composition for enhancing newborn infant cognitive, brain and/or cns development and method of using same | |
WO2019154879A1 (en) | Composition comprising spray dried roe | |
GB2217173A (en) | Nutritional and medicinal compositions | |
WO2020225217A1 (en) | Omega-3 beverage | |
KR20050007718A (en) | A composition containing docosahexaenoic acid | |
JP2009159990A (en) | Highly nutritive food | |
JP2002159279A (en) | Improving agent with ability to utilize oxygen | |
JP7069531B2 (en) | Capsules containing pyrroloquinoline quinone or a salt thereof and branched chain amino acids | |
JP6734101B2 (en) | Heart rate recovery promoting composition | |
JP6111353B2 (en) | Superabsorbent oral composition | |
RU2757319C1 (en) | Semi-finished meat-vegetable minced functional enriched | |
JP6446200B2 (en) | Oil-in-water emulsified jelly in paper container | |
JPH0987619A (en) | Production of antioxidant | |
EP4066892A1 (en) | Composition for enteral intake |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 19707705 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 19707705 Country of ref document: EP Kind code of ref document: A1 |